syndrome	score	normalized_score
COMPLEX REGIONAL PAIN SYNDROME	1.25	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0166667	81.333336
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	80.952384
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.000961538	80.07692304
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0	80.0
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	1.0	80.0
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.6776316	54.210528000000004
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.6146075	49.1686
DUPLICATION/INVERSION 15Q11	0.6120725379999999	48.96580304
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.553333	44.266639999999995
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.5294118	42.352944
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5277778	42.222224
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.52	41.6
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.500961538	40.076923040000004
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.5	40.0
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.41760904	33.408723200000004
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.4102561	32.820488000000005
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.4051947	32.415576
SPINOCEREBELLAR ATAXIA TYPE 42	0.4047616	32.380928
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.3522009	28.176071999999998
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.34068593999999996	27.254875199999994
PIERPONT SYNDROME	0.33996125	27.196900000000003
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.3368295	26.946360000000002
RARE CIRCULATORY SYSTEM DISEASE	0.333333	26.666639999999997
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.333333	26.666639999999997
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	26.666639999999997
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.333333	26.666639999999997
PLACENTAL INSUFFICIENCY	0.333333	26.666639999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.333333	26.666639999999997
INSULINOMA	0.333333	26.666639999999997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.2792206	22.337647999999998
POTOCKI-LUPSKI SYNDROME	0.25651713800000003	20.521371040000002
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.2555556	20.444447999999998
CHILDHOOD APRAXIA OF SPEECH	0.2555556	20.444447999999998
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.2534091	20.272728
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.250961538	20.07692304
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.25	20.0
EPISODIC PAIN SYNDROME, FAMILIAL, 2	0.25	20.0
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.2490602	19.924816
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.23376609999999998	18.701287999999998
NAVAJO NEUROHEPATOPATHY	0.208004938	16.64039504
CRI-DU-CHAT SYNDROME	0.20190476000000002	16.152380800000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.20096153800000002	16.07692304
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.20096153800000002	16.07692304
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	16.0
TRANSALDOLASE DEFICIENCY	0.2	16.0
CLEFT VELUM	0.2	16.0
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.19763160000000002	15.810528000000001
SPINOCEREBELLAR ATAXIA TYPE 4	0.1948447	15.587576
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.1909091	15.272727999999999
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.1881662	15.053296
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.1868902	14.951216
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.18172489999999997	14.537991999999997
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.1813679	14.509432
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.1776316	14.210528
INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY	0.1776316	14.210528
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.1776316	14.210528
MARSILI SYNDROME; MARSIS	0.1776316	14.210528
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17168187000000001	13.734549600000001
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.16789399000000002	13.431519200000002
CEREBROOCULONASAL SYNDROME	0.166667	13.333359999999999
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	13.333359999999999
DERMATOLEUKODYSTROPHY	0.166667	13.333359999999999
MUCOLIPIDOSIS TYPE II	0.166667	13.333359999999999
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.1637426	13.099407999999999
SPINOCEREBELLAR ATAXIA TYPE 25	0.16285699999999997	13.028559999999997
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.16172489999999998	12.937991999999998
CHARCOT-MARIE-TOOTH SYNDROME TYPE 1A (CMT1A)	0.1612733	12.901864000000002
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.15829100000000002	12.663280000000002
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.150351738	12.028139040000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.1493902	11.951216
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.14285699999999998	11.42856
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.13942310000000002	11.153848000000002
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.13714924800000003	10.971939840000003
SPINOCEREBELLAR ATAXIA TYPE 23	0.1363636	10.909088
NON-DISTAL MONOSOMY 20Q	0.132072538	10.565803039999999
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.13117284	10.493827200000002
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.12718852800000002	10.175082240000002
NIEMANN-PICK DISEASE, TYPE C2	0.12718852800000002	10.175082240000002
LATHOSTEROLOSIS	0.12718852800000002	10.175082240000002
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.125	10.0
SINDING-LARSEN-JOHANSSON DISEASE	0.125	10.0
MYCETOMA	0.125	10.0
PERINEURAL CYST	0.125	10.0
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.125	10.0
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.125	10.0
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.12359139	9.8873112
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.12317174000000002	9.853739200000001
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.1188679	9.509432
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.11460749999999999	9.1686
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.11460749999999999	9.1686
COFFIN-SIRIS SYNDROME 1; CSS1	0.11233798999999998	8.9870392
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.11207253799999999	8.965803039999999
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11207253799999999	8.965803039999999
TRICHOHEPATOENTERIC SYNDROME 1	0.10633490000000001	8.506792
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.10617284	8.4938272
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.102274838	8.181987040000001
HENNEKAM-BEEMER SYNDROME	0.10122699	8.098159200000001
ESOPHAGEAL ATRESIA	0.10122699	8.098159200000001
BEHÇET DISEASE	0.1	8.0
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	8.0
ACQUIRED ICHTHYOSIS	0.1	8.0
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	8.0
DRACUNCULIASIS	0.1	8.0
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.1	8.0
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.1	8.0
INTESTINAL LYMPHANGIECTASIA	0.1	8.0
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.09826204000000001	7.860963200000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.09826204000000001	7.860963200000001
SPINOCEREBELLAR ATAXIA TYPE 13	0.091870638	7.34965104
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.09142860000000001	7.314288
STIFF SKIN SYNDROME	0.09142860000000001	7.314288
TANGIER DISEASE; TGD	0.09142860000000001	7.314288
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0909091	7.272728000000001
RHEUMATOID ARTHRITIS	0.0901315	7.210520000000001
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.087851738	7.02813904
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.086464568	6.917165440000001
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.08523816000000001	6.8190528
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0848897	6.791176
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.08427604000000001	6.7420832000000015
SYSTEMIC MASTOCYTOSIS	0.0833334	6.666672
MASTOCYTOSIS	0.0833334	6.666672
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.08232943799999999	6.58635504
TRISOMY 8P	0.077884638	6.2307710400000005
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.077884638	6.2307710400000005
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.077884638	6.2307710400000005
DDOST-CDG	0.077884638	6.2307710400000005
ETHYLMALONIC ENCEPHALOPATHY	0.077884638	6.2307710400000005
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.07719764000000001	6.175811200000001
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	6.153848000000001
SECONDARY SYRINGOMYELIA	0.07692310000000001	6.153848000000001
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	6.153848000000001
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.07692310000000001	6.153848000000001
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.07692310000000001	6.153848000000001
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.07692310000000001	6.153848000000001
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	6.153848000000001
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	6.153848000000001
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	6.153848000000001
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	6.153848000000001
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	6.153848000000001
HYDROXYKYNURENINURIA	0.07573640000000001	6.058912000000001
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.07492510000000001	5.994008000000001
PRADER-WILLI SYNDROME	0.07333336000000001	5.866668800000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.07333336000000001	5.866668800000001
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.07333336000000001	5.866668800000001
SLC35A2-CDG	0.0728901	5.831208
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.07265559	5.8124472
GRISCELLI SYNDROME	0.07265559	5.8124472
KENNEDY DISEASE	0.07265559	5.8124472
WILLIAMS SYNDROME	0.07265559	5.8124472
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.07174946000000001	5.739956800000002
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.07174946	5.7399568
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	5.714288000000001
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.07142860000000001	5.714288000000001
PACHYDERMOPERIOSTOSIS	0.07142860000000001	5.714288000000001
BATHING SUIT ICHTHYOSIS	0.07142860000000001	5.714288000000001
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07142860000000001	5.714288000000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	5.714288000000001
ADRENOLEUKODYSTROPHY	0.07142860000000001	5.714288000000001
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.07142860000000001	5.714288000000001
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.07142860000000001	5.714288000000001
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.07142860000000001	5.714288000000001
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	5.714288000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.07142860000000001	5.714288000000001
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07142860000000001	5.714288000000001
INDOLENT SYSTEMIC MASTOCYTOSIS	0.07142860000000001	5.714288000000001
ADULT-ONSET STILL DISEASE	0.07142860000000001	5.714288000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.07142860000000001	5.714288000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.07142860000000001	5.714288000000001
SPINOCEREBELLAR ATAXIA 14	0.07142860000000001	5.714288000000001
SPINOCEREBELLAR ATAXIA 42	0.07142860000000001	5.714288000000001
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.07142860000000001	5.714288000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.07142860000000001	5.714288000000001
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	5.714288000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.06985294	5.588235200000001
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.06985294	5.588235200000001
POSTERIOR COLUMN ATAXIA	0.06984470000000001	5.587576000000001
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.06984470000000001	5.587576000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.06984470000000001	5.587576000000001
SMITH-MAGENIS SYNDROME; SMS	0.068944798	5.515583840000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.0643224	5.145792
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0643224	5.145792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.0643224	5.145792
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0643224	5.145792
SPINOCEREBELLAR ATAXIA 46; SCA46	0.0625	5.0
PERRAULT SYNDROME 5; PRLTS5	0.0625	5.0
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0625	5.0
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.0625	5.0
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.05678259	4.5426072
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.05678259	4.5426072
17P11.2 MICRODUPLICATION SYNDROME	0.05678259	4.5426072
8Q24.3 MICRODELETION SYNDROME	0.056517138	4.52137104
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.056517138	4.52137104
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.056517138	4.52137104
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.056517138	4.52137104
SIALURIA	0.056517138	4.52137104
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	4.444448
FLOATING-HARBOR SYNDROME	0.055555600000000004	4.444448
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	4.444448
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	4.444448
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	4.444448
FLOATING-HARBOR SYNDROME	0.055555600000000004	4.444448
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.053593138	4.28745104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.052807440000000004	4.2245952
CENTRAL NEUROCYTOMA	0.0526316	4.210528
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0526316	4.210528
MALIGNANT ATROPHIC PAPULOSIS	0.0526316	4.210528
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0526316	4.210528
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0526316	4.210528
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.0526316	4.210528
CHROMOSOME 2Q37 DELETION SYNDROME	0.0526316	4.210528
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0522581	4.180648
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.05083124000000001	4.0664992
DOWN SYNDROME	0.04979839	3.9838712
ERYTHERMALGIA, PRIMARY	0.0494995	3.9599599999999997
AMYLOIDOSIS	0.0494118	3.952944
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.047266180000000005	3.7812944
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.04646509	3.7172072
SPINOCEREBELLAR ATAXIA TYPE 1	0.046416038	3.71328304
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	3.665024
PSEUDOTRISOMY 13 SYNDROME	0.045666828	3.6533462400000003
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.0454545	3.6363600000000003
FRIEDREICH ATAXIA	0.0454545	3.6363600000000003
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.0454545	3.6363600000000003
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.0454545	3.6363600000000003
CHYLOMICRON RETENTION DISEASE	0.0454545	3.6363600000000003
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0444445	3.55556
NETHERTON SYNDROME; NETH	0.0441629	3.533032
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	3.4782640000000002
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	3.4782640000000002
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	3.4782640000000002
JUVENILE XANTHOGRANULOMA	0.043478300000000004	3.4782640000000002
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	3.4782640000000002
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	3.4782640000000002
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	3.4782640000000002
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	3.4782640000000002
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	3.4782640000000002
HYPOPLASMINOGENEMIA	0.043478300000000004	3.4782640000000002
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	3.4782640000000002
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	3.4782640000000002
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	3.4782640000000002
NEUROFIBROMATOSIS TYPE 1	0.043478300000000004	3.4782640000000002
LICHTENSTEIN SYNDROME	0.043478300000000004	3.4782640000000002
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	3.4782640000000002
IMMUNODEFICIENCY 23; IMD23	0.040644138	3.2515310400000006
SMITH-MAGENIS SYNDROME	0.03979844999999999	3.1838759999999993
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0396826	3.1746079999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.038620897999999994	3.0896718399999994
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.03676474	2.9411792
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	2.8836783999999995
COFS SYNDROME	0.03597123	2.8776984
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03558464	2.8467712
CONGENITAL DISORDER OF GLYCOSYLATION	0.03474424	2.7795392000000003
ACRODYSOSTOSIS	0.03474424	2.7795392000000003
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.034162859999999996	2.7330287999999996
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	2.6559744
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	2.6559744
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	2.6559744
STÜVE-WIEDEMANN SYNDROME	0.03313179	2.6505432000000004
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.032866338	2.62930704
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	2.580648
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	2.580648
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	2.580648
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	2.580648
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	2.580648
DESMOID TUMOR	0.0322581	2.580648
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	2.580648
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	2.580648
INFANTILE MYOFIBROMATOSIS	0.0322581	2.580648
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	2.580648
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	2.580648
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	2.580648
THROMBOCYTOPENIA 1	0.0322581	2.580648
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	2.580648
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	2.580648
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	2.580648
ROWLEY-ROSENBERG SYNDROME	0.0322581	2.580648
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	2.580648
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	2.580648
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.03174314	2.5394512000000002
22Q11.2 MICRODUPLICATION SYNDROME	0.03170315	2.536252
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.031600328	2.5280262399999995
X-LINKED ADRENOLEUKODYSTROPHY	0.03156568	2.5252543999999997
SHORT SYNDROME	0.03131656	2.5053248
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.030644098	2.45152784
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.03063879	2.4511032
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030373338	2.42986704
CHARGE SYNDROME	0.02979839	2.3838712
PENTASOMY X	0.02979839	2.3838712
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.02979839	2.3838712
COG7-CDG	0.02979839	2.3838712
NORRIE DISEASE	0.02979839	2.3838712
SOTOS SYNDROME	0.02979839	2.3838712
DISTAL MONOSOMY 7Q36	0.02979839	2.3838712
GALLOWAY-MOWAT SYNDROME	0.02979839	2.3838712
ALG12-CDG	0.02979839	2.3838712
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.02979839	2.3838712
C SYNDROME	0.02979839	2.3838712
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.02979839	2.3838712
TETRASOMY X	0.02979839	2.3838712
MYASTHENIA GRAVIS; MG	0.0294118	2.352944
IMMUNE SUPPRESSION	0.0294118	2.352944
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	2.352944
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	2.352944
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	2.352944
ECHO VIRUS 11 SENSITIVITY	0.0294118	2.352944
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	2.352944
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	2.352944
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	2.352944
RAGWEED SENSITIVITY	0.0294118	2.352944
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	2.352944
MONOMELIC AMYOTROPHY	0.0294118	2.352944
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	2.352944
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	2.352944
SPINOCEREBELLAR ATAXIA TYPE 14	0.028739338000000003	2.2991470400000003
SUSAC SYNDROME	0.028739338000000003	2.2991470400000003
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.028739338000000003	2.2991470400000003
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	2.285712
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	2.285712
CHEILITIS GLANDULARIS	0.0285714	2.285712
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0285714	2.285712
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	2.285712
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0285714	2.285712
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	2.285712
FETAL ALCOHOL SYNDROME	0.0285714	2.285712
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	2.285712
CONGENITAL LOBAR EMPHYSEMA	0.0285714	2.285712
PROPIONIC ACIDEMIA	0.0285714	2.285712
SCHWARTZ-JAMPEL SYNDROME	0.0285714	2.285712
ALPHA-THALASSEMIA	0.0285714	2.285712
ALG1-CDG	0.0285714	2.285712
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	2.285712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.027777800000000002	2.222224
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.027777800000000002	2.222224
TRIGEMINAL NEURALGIA	0.027777800000000002	2.222224
SPINOCEREBELLAR ATAXIA TYPE 18	0.027777800000000002	2.222224
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.027777800000000002	2.222224
SPINOCEREBELLAR ATAXIA TYPE 37	0.027777800000000002	2.222224
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.027777800000000002	2.222224
REFSUM DISEASE	0.027777800000000002	2.222224
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.027777800000000002	2.222224
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.027777800000000002	2.222224
MEGALOBLASTIC ANEMIA 1	0.027777800000000002	2.222224
NEUROMYELITIS OPTICA	0.027777800000000002	2.222224
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.027777800000000002	2.222224
CORTICOBASAL SYNDROME	0.027777800000000002	2.222224
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.027777800000000002	2.222224
SPINOCEREBELLAR ATAXIA TYPE 7	0.027777800000000002	2.222224
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.027777800000000002	2.222224
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.027777800000000002	2.222224
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.027777800000000002	2.222224
ARNOLD-CHIARI MALFORMATION TYPE I	0.027777800000000002	2.222224
ABETAL34V AMYLOIDOSIS	0.027777800000000002	2.222224
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.027777800000000002	2.222224
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.027777800000000002	2.222224
SPINOCEREBELLAR ATAXIA TYPE 38	0.027777800000000002	2.222224
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.027777800000000002	2.222224
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.027777800000000002	2.222224
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.027256498	2.18051984
SPINOCEREBELLAR ATAXIA 2; SCA2	0.026578728000000003	2.12629824
SPINOCEREBELLAR ATAXIA 1	0.026578728000000003	2.12629824
POLYNEUROPATHY ASSOCIATED WITH IGM MONOCLONAL GAMMAPATHY WITH ANTI-MAG	0.02622084	2.0976671999999996
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.02622084	2.0976671999999996
ATAXIA-PANCYTOPENIA SYNDROME	0.02622084	2.0976671999999996
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.02622084	2.0976671999999996
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.025351738000000002	2.02813904
SPINOCEREBELLAR ATAXIA 5; SCA5	0.025351738000000002	2.02813904
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.025351738000000002	2.02813904
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.025351738000000002	2.02813904
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.024458038	1.9566430400000001
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0243902	1.951216
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.0243902	1.951216
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.0243902	1.951216
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0243902	1.951216
SPINOCEREBELLAR ATAXIA TYPE 8	0.0243902	1.951216
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.0243902	1.951216
SPINOCEREBELLAR ATAXIA TYPE 31	0.0243902	1.951216
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.0243902	1.951216
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.0243902	1.951216
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0243902	1.951216
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0243902	1.951216
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0243902	1.951216
MYOPATHY AND DIABETES MELLITUS	0.0243902	1.951216
CHYLOMICRON RETENTION DISEASE	0.0243902	1.951216
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.0243902	1.951216
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0243902	1.951216
MACHADO-JOSEPH DISEASE; MJD	0.0243902	1.951216
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.02401964	1.9215712
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.02401964	1.9215712
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.02401964	1.9215712
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.0234965	1.87972
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.02313175	1.8505399999999999
16P11.2P12.2 MICRODELETION SYNDROME	0.02313175	1.8505399999999999
XQ12-Q13.3 DUPLICATION SYNDROME	0.02313175	1.8505399999999999
PRADER-WILLI SYNDROME; PWS	0.022866298	1.82930384
PHELAN-MCDERMID SYNDROME	0.022866298	1.82930384
RING CHROMOSOME 22 SYNDROME	0.022866298	1.82930384
DISTAL MONOSOMY 12Q	0.022866298	1.82930384
CEREBROTENDINOUS XANTHOMATOSIS	0.02283954	1.8271632
STUVE-WIEDEMANN SYNDROME	0.022188528000000002	1.7750822400000001
MONOSOMY 22Q13.3	0.02190476	1.7523807999999998
13Q12.3 MICRODELETION SYNDROME	0.02190476	1.7523807999999998
FAMILIAL DYSAUTONOMIA	0.02122699	1.6981592
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.6823424
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.6823424
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.6823424
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.6823424
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.6823424
COG4-CDG	0.0201632	1.6130559999999998
FLYNN-AIRD SYNDROME	0.02	1.6
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.02	1.6
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.02	1.6
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.02	1.6
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.02	1.6
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.02	1.6
CADASIL	0.02	1.6
ISOLATED HEMIHYPERPLASIA	0.02	1.6
GEMIGNANI SYNDROME	0.02	1.6
HEREDITARY SPASTIC PARAPLEGIA	0.02	1.6
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.02	1.6
PAROXYSMAL EXTREME PAIN DISORDER	0.02	1.6
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.02	1.6
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.02	1.6
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.02	1.6
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.02	1.6
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.02	1.6
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.02	1.6
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.02	1.6
TEMPLE SYNDROME	0.019532998	1.56263984
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA TYPE 7	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0188679	1.5094319999999999
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0188679	1.5094319999999999
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0188679	1.5094319999999999
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0188679	1.5094319999999999
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0188679	1.5094319999999999
SPINOCEREBELLAR ATAXIA 23; SCA23	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0188679	1.5094319999999999
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.0188679	1.5094319999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.0188679	1.5094319999999999
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.0188679	1.5094319999999999
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.018855228	1.5084182400000001
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.018571459999999998	1.4857167999999998
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.018571459999999998	1.4857167999999998
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.018571459999999998	1.4857167999999998
MOSAIC TRISOMY 15	0.01846839	1.4774712
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.01807764	1.4462112
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.01807764	1.4462112
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.017628238	1.41025904
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.017628238	1.41025904
PALMOMENTAL REFLEX	0.0172414	1.379312
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.379312
MOTION SICKNESS	0.0172414	1.379312
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.379312
MYOPATHY, CONGENITAL	0.0172414	1.379312
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.379312
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.379312
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.379312
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.379312
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.379312
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.379312
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.379312
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.379312
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.379312
269800 SENILE PLAQUE FORMATION	0.0172414	1.379312
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.379312
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.379312
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.379312
SICKLE CELL ANEMIA	0.0172414	1.379312
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.379312
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.379312
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.379312
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.379312
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.379312
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.379312
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.379312
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.379312
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.379312
TRANSSEXUALITY	0.0172414	1.379312
CARDIAC ARRHYTHMIA	0.0172414	1.379312
JUMPING FRENCHMAN OF MAINE	0.0172414	1.379312
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.379312
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.379312
ALCOHOL DEPENDENCE	0.0172414	1.379312
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.379312
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.379312
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.379312
THUMBS, CONGENITAL CLASPED	0.0172414	1.379312
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.379312
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.379312
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.379312
DIASTEMATOMYELIA	0.0172414	1.379312
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.379312
CERVICAL RIB	0.0172414	1.379312
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.379312
CUSHING SYNDROME	0.0166667	1.3333359999999999
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	0.0166667	1.3333359999999999
DYSBETALIPOPROTEINEMIA	0.0166667	1.3333359999999999
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.0166667	1.3333359999999999
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0166667	1.3333359999999999
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.0166667	1.3333359999999999
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0166667	1.3333359999999999
GLYCOGEN STORAGE DISEASE IXA	0.0166667	1.3333359999999999
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0166667	1.3333359999999999
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0166667	1.3333359999999999
MANDIBULOACRAL DYSPLASIA	0.0166667	1.3333359999999999
LOWE OCULOCEREBRORENAL SYNDROME	0.0166667	1.3333359999999999
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0166667	1.3333359999999999
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.0166667	1.3333359999999999
HYPERLIPOPROTEINEMIA, TYPE I	0.0166667	1.3333359999999999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0166667	1.3333359999999999
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0166667	1.3333359999999999
LARON SYNDROME	0.0166667	1.3333359999999999
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0166667	1.3333359999999999
CITRULLINEMIA TYPE II	0.0166667	1.3333359999999999
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.0166667	1.3333359999999999
LYSINURIC PROTEIN INTOLERANCE	0.0166667	1.3333359999999999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0166667	1.3333359999999999
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0166667	1.3333359999999999
CHOLESTERYL ESTER STORAGE DISEASE	0.0166667	1.3333359999999999
CONGENITAL ANALBUMINEMIA	0.0166667	1.3333359999999999
DISTAL MYOPATHY, TATEYAMA TYPE	0.0166667	1.3333359999999999
SITOSTEROLEMIA	0.0166667	1.3333359999999999
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0166667	1.3333359999999999
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0166667	1.3333359999999999
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0166667	1.3333359999999999
ALAGILLE SYNDROME 1; ALGS1	0.0166667	1.3333359999999999
HYPERCHOLESTEROLEMIA, FAMILIAL	0.0166667	1.3333359999999999
XANTHOMATOSIS, SUSCEPTIBILITY TO	0.0166667	1.3333359999999999
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0166667	1.3333359999999999
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.0166667	1.3333359999999999
GLYCOGEN STORAGE DISEASE VI	0.0166667	1.3333359999999999
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0166667	1.3333359999999999
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0166667	1.3333359999999999
DERMATITIS, ATOPIC	0.015692679999999997	1.2554143999999998
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.0154013	1.232104
16P13.2 MICRODELETION SYNDROME	0.0154013	1.232104
48,XXXY SYNDROME	0.01503655	1.202924
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.014771097999999998	1.1816878399999997
CHROMOSOME 18Q DELETION SYNDROME	0.014093327999999999	1.12746624
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.014093327999999999	1.12746624
48,XYYY SYNDROME	0.013809559999999999	1.1047647999999999
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.013809559999999999	1.1047647999999999
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.013809559999999999	1.1047647999999999
47,XYY SYNDROME	0.013809559999999999	1.1047647999999999
9Q33.3Q34.11 MICRODELETION SYNDROME	0.013809559999999999	1.1047647999999999
PRIMARY CILIARY DYSKINESIA	0.013809559999999999	1.1047647999999999
BARDET-BIEDL SYNDROME 1; BBS1	0.013809559999999999	1.1047647999999999
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.01352578	1.0820623999999999
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.01352578	1.0820623999999999
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.01352578	1.0820623999999999
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.01352578	1.0820623999999999
22Q11.2 DELETION SYNDROME	0.013131789999999999	1.0505432
48,XXYY SYNDROME	0.013131789999999999	1.0505432
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.013131789999999999	1.0505432
49,XXXXY SYNDROME	0.013131789999999999	1.0505432
CLASSICAL EHLERS-DANLOS SYNDROME	0.013131789999999999	1.0505432
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.9523839999999999
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	0.9523839999999999
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.9523839999999999
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.9523839999999999
YAO SYNDROME	0.011904799999999998	0.9523839999999999
DUBOWITZ SYNDROME	0.011904799999999998	0.9523839999999999
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.9523839999999999
MUCOPOLYSACCHARIDOSIS, TYPE II	0.011904799999999998	0.9523839999999999
AORTIC ARCH DEFECTS	0.011904799999999998	0.9523839999999999
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.9523839999999999
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.9523839999999999
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	0.9523839999999999
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011904799999999998	0.9523839999999999
SECKEL SYNDROME 9; SCKL9	0.011904799999999998	0.9523839999999999
TRANSALDOLASE DEFICIENCY	0.011904799999999998	0.9523839999999999
CYSTIC FIBROSIS	0.011904799999999998	0.9523839999999999
BRAIN-LUNG-THYROID SYNDROME	0.011904799999999998	0.9523839999999999
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.9523839999999999
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	0.9523839999999999
CASPASE 8 DEFICIENCY	0.011904799999999998	0.9523839999999999
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.9523839999999999
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	0.9523839999999999
ALSTRÖM SYNDROME	0.011904799999999998	0.9523839999999999
OCULO-PALATO-CEREBRAL SYNDROME	0.011904799999999998	0.9523839999999999
BERNARD-SOULIER SYNDROME	0.011904799999999998	0.9523839999999999
CHILBLAIN LUPUS	0.011904799999999998	0.9523839999999999
IMMUNODEFICIENCY 58; IMD58	0.011904799999999998	0.9523839999999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	0.9523839999999999
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	0.9523839999999999
ICHTHYOSIS VULGARIS	0.011904799999999998	0.9523839999999999
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.9523839999999999
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.9523839999999999
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.9523839999999999
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	0.9523839999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.011904799999999998	0.9523839999999999
CARCINOID SYNDROME	0.011904799999999998	0.9523839999999999
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.9523839999999999
ALSTROM SYNDROME; ALMS	0.011904799999999998	0.9523839999999999
PGM3-CDG	0.011904799999999998	0.9523839999999999
MYOTONIA PERMANENS	0.011904799999999998	0.9523839999999999
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.011904799999999998	0.9523839999999999
NETHERTON SYNDROME	0.011904799999999998	0.9523839999999999
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.9523839999999999
MICROFORM HOLOPROSENCEPHALY	0.011904799999999998	0.9523839999999999
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.011904799999999998	0.9523839999999999
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	0.9523839999999999
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.9523839999999999
REFSUM DISEASE	0.01118771	0.8950168
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.01114082	0.8912656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.010630878	0.8504702399999999
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.010219238	0.81753904
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.010219238	0.81753904
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00996072	0.7968575999999999
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00966934	0.7735472
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.009257699999999999	0.7406159999999999
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.008361368	0.66890944
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.008361368	0.66890944
FOLATE MALABSORPTION, HEREDITARY	0.008361368	0.66890944
PEROXISOME BIOGENESIS DISORDER 6B	0.008314478	0.66515824
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.008314478	0.66515824
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008314478	0.66515824
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.008314478	0.66515824
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.008314478	0.66515824
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.008314478	0.66515824
GIANT AXONAL NEUROPATHY	0.008314478	0.66515824
FAMILIAL MULTIPLE LIPOMATOSIS	0.008077599999999999	0.6462079999999999
PMM2-CDG	0.008077599999999999	0.6462079999999999
MACHADO-JOSEPH DISEASE TYPE 1	0.008077599999999999	0.6462079999999999
MACHADO-JOSEPH DISEASE TYPE 2	0.008077599999999999	0.6462079999999999
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.008077599999999999	0.6462079999999999
MOEBIUS SYNDROME; MBS	0.008077599999999999	0.6462079999999999
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.007881168000000001	0.6304934400000001
EMANUEL SYNDROME	0.007881168000000001	0.6304934400000001
SALLA DISEASE	0.007881168000000001	0.6304934400000001
CHROMOSOME 10Q26 DELETION SYNDROME	0.007881168000000001	0.6304934400000001
EPILEPSY, PYRIDOXINE-DEPENDENT	0.007881168000000001	0.6304934400000001
ASPARTYLGLUCOSAMINURIA; AGU	0.007881168000000001	0.6304934400000001
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.007881168000000001	0.6304934400000001
CHROMOSOME 16P13.2 DELETION SYNDROME	0.007589788	0.60718304
METACHROMATIC LEUKODYSTROPHY	0.00739983	0.5919863999999999
PELIZAEUS-MERZBACHER DISEASE	0.00739983	0.5919863999999999
CORNELIA DE LANGE SYNDROME	0.00739983	0.5919863999999999
MICRO SYNDROME	0.00739983	0.5919863999999999
CHOREOACANTHOCYTOSIS	0.00739983	0.5919863999999999
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00739983	0.5919863999999999
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00739983	0.5919863999999999
MARINESCO-SJÖGREN SYNDROME	0.00739983	0.5919863999999999
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00739983	0.5919863999999999
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00739983	0.5919863999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00739983	0.5919863999999999
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00739983	0.5919863999999999
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00739983	0.5919863999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00735294	0.5882352
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00735294	0.5882352
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.00735294	0.5882352
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00735294	0.5882352
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00735294	0.5882352
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00735294	0.5882352
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00735294	0.5882352
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.00735294	0.5882352
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.00735294	0.5882352
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.00735294	0.5882352
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00735294	0.5882352
ISAAC SYNDROME	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00735294	0.5882352
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00735294	0.5882352
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00735294	0.5882352
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00735294	0.5882352
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00735294	0.5882352
KUFOR-RAKEB SYNDROME	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00735294	0.5882352
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00735294	0.5882352
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00735294	0.5882352
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00735294	0.5882352
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00735294	0.5882352
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00735294	0.5882352
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00735294	0.5882352
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.00735294	0.5882352
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00735294	0.5882352
SPINOCEREBELLAR ATAXIA TYPE 43	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00735294	0.5882352
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.00735294	0.5882352
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00735294	0.5882352
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00735294	0.5882352
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00735294	0.5882352
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00735294	0.5882352
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00735294	0.5882352
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.00735294	0.5882352
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00735294	0.5882352
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00735294	0.5882352
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00735294	0.5882352
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00735294	0.5882352
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00735294	0.5882352
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00735294	0.5882352
DEAFNESS, X-LINKED 5; DFNX5	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00735294	0.5882352
ADULT POLYGLUCOSAN BODY DISEASE	0.00735294	0.5882352
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.00735294	0.5882352
COWCHOCK SYNDROME; COWCK	0.00735294	0.5882352
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00735294	0.5882352
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00735294	0.5882352
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00728438	0.5827504
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007134378	0.57075024
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.007134378	0.57075024
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.007134378	0.57075024
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.007134378	0.57075024
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007134378	0.57075024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007134378	0.57075024
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.007134378	0.57075024
TRICHOTHIODYSTROPHY	0.007134378	0.57075024
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007134378	0.57075024
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006654178	0.53233424
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.006362798000000001	0.50902384
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.006362798000000001	0.50902384
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006362798000000001	0.50902384
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.00617284	0.49382719999999997
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00617284	0.49382719999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.00617284	0.49382719999999997
FLYNN-AIRD SYNDROME	0.00617284	0.49382719999999997
NEUROFIBROMATOSIS, TYPE II	0.00617284	0.49382719999999997
CEDNIK SYNDROME	0.00617284	0.49382719999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00617284	0.49382719999999997
PORPHYRIA VARIEGATA	0.00617284	0.49382719999999997
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00617284	0.49382719999999997
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00617284	0.49382719999999997
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.00617284	0.49382719999999997
CRANIAL NERVES, RECURRENT PARESIS OF	0.00617284	0.49382719999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00617284	0.49382719999999997
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00617284	0.49382719999999997
SÉZARY SYNDROME	0.00617284	0.49382719999999997
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00617284	0.49382719999999997
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.00617284	0.49382719999999997
NEUROPATHY, PAINFUL	0.00617284	0.49382719999999997
LEGIONELLOSIS	0.00617284	0.49382719999999997
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.00617284	0.49382719999999997
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00617284	0.49382719999999997
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00617284	0.49382719999999997
WISKOTT-ALDRICH SYNDROME	0.00617284	0.49382719999999997
CARPAL TUNNEL SYNDROME	0.00617284	0.49382719999999997
STIFF SKIN SYNDROME	0.00617284	0.49382719999999997
WOLFRAM SYNDROME	0.00617284	0.49382719999999997
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00617284	0.49382719999999997
XERODERMA PIGMENTOSUM	0.00617284	0.49382719999999997
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00617284	0.49382719999999997
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00617284	0.49382719999999997
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.00617284	0.49382719999999997
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.00617284	0.49382719999999997
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00617284	0.49382719999999997
WHIPPLE DISEASE	0.00617284	0.49382719999999997
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00617284	0.49382719999999997
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.00617284	0.49382719999999997
AMERICAN TRYPANOSOMIASIS	0.00617284	0.49382719999999997
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00617284	0.49382719999999997
HODGKIN LYMPHOMA	0.00617284	0.49382719999999997
MIXED CONNECTIVE TISSUE DISEASE	0.00617284	0.49382719999999997
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00617284	0.49382719999999997
DYSAUTONOMIA-LIKE DISORDER	0.00617284	0.49382719999999997
ACROOSTEOLYSIS DOMINANT TYPE	0.00617284	0.49382719999999997
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00617284	0.49382719999999997
SYSTEMIC SCLEROSIS	0.00617284	0.49382719999999997
SCLERODERMA	0.00617284	0.49382719999999997
CLASSIC HODGKIN LYMPHOMA	0.00617284	0.49382719999999997
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00617284	0.49382719999999997
NIEMANN-PICK DISEASE TYPE B	0.00617284	0.49382719999999997
LEBER OPTIC ATROPHY AND DYSTONIA	0.00617284	0.49382719999999997
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00617284	0.49382719999999997
FELTY SYNDROME	0.00617284	0.49382719999999997
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00617284	0.49382719999999997
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00617284	0.49382719999999997
GAMMA-HEAVY CHAIN DISEASE	0.00617284	0.49382719999999997
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.00617284	0.49382719999999997
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00617284	0.49382719999999997
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00617284	0.49382719999999997
DEND SYNDROME	0.00617284	0.49382719999999997
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00617284	0.49382719999999997
IRIDA SYNDROME	0.00617284	0.49382719999999997
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00617284	0.49382719999999997
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00617284	0.49382719999999997
DISORDER OF BILE ACID SYNTHESIS	0.00617284	0.49382719999999997
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00617284	0.49382719999999997
PRIMARY HYPEROXALURIA	0.00617284	0.49382719999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00617284	0.49382719999999997
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00617284	0.49382719999999997
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00617284	0.49382719999999997
OSTEOPETROSIS AND RELATED DISORDERS	0.00617284	0.49382719999999997
COCKAYNE SYNDROME	0.00617284	0.49382719999999997
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00617284	0.49382719999999997
THALIDOMIDE SUSCEPTIBILITY	0.00617284	0.49382719999999997
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00617284	0.49382719999999997
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00617284	0.49382719999999997
RABSON-MENDENHALL SYNDROME	0.00617284	0.49382719999999997
WALDENSTRÖM MACROGLOBULINEMIA	0.00617284	0.49382719999999997
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00617284	0.49382719999999997
MAST SYNDROME	0.00617284	0.49382719999999997
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00617284	0.49382719999999997
LEBER HEREDITARY OPTIC NEUROPATHY	0.00617284	0.49382719999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00617284	0.49382719999999997
SPINOCEREBELLAR ATAXIA TYPE 11	0.00617284	0.49382719999999997
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00617284	0.49382719999999997
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00617284	0.49382719999999997
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.00617284	0.49382719999999997
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00617284	0.49382719999999997
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00617284	0.49382719999999997
DISTAL MYOTILINOPATHY	0.00617284	0.49382719999999997
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.00617284	0.49382719999999997
MEDNIK SYNDROME	0.00617284	0.49382719999999997
NON-HISTAMINIC ANGIOEDEMA	0.00617284	0.49382719999999997
SARCOIDOSIS	0.00617284	0.49382719999999997
DOORS SYNDROME	0.00617284	0.49382719999999997
SCHNITZLER SYNDROME	0.00617284	0.49382719999999997
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00617284	0.49382719999999997
HEREDITARY FOLATE MALABSORPTION	0.00617284	0.49382719999999997
PRIMARY ERYTHROMELALGIA	0.00617284	0.49382719999999997
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.005976408000000001	0.47811264000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.005976408000000001	0.47811264000000003
XYLOSIDASE DEFICIENCY	0.005976408000000001	0.47811264000000003
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005976408000000001	0.47811264000000003
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.005976408000000001	0.47811264000000003
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.005976408000000001	0.47811264000000003
LARSEN-LIKE SYNDROME	0.005976408000000001	0.47811264000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.005976408000000001	0.47811264000000003
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005976408000000001	0.47811264000000003
EHLERS-DANLOS SYNDROME, TYPE VI	0.005976408000000001	0.47811264000000003
BARAITSER-WINTER SYNDROME 1; BRWS1	0.005976408000000001	0.47811264000000003
PITT-HOPKINS SYNDROME	0.005685028	0.45480223999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005685028	0.45480223999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005685028	0.45480223999999997
HADZISELIMOVIC SYNDROME	0.005685028	0.45480223999999997
MUCOLIPIDOSIS IV; ML4	0.005685028	0.45480223999999997
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.005685028	0.45480223999999997
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005685028	0.45480223999999997
ANGELMAN SYNDROME	0.005685028	0.45480223999999997
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005685028	0.45480223999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.005401260000000001	0.4321008
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00501487	0.4011896
NEURONAL CEROID LIPOFUSCINOSIS	0.00501487	0.4011896
NEONATAL ADRENOLEUKODYSTROPHY	0.00501487	0.4011896
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00501487	0.4011896
PYRIDOXINE-DEPENDENT EPILEPSY	0.00501487	0.4011896
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00501487	0.4011896
CUTIS LAXA	0.00501487	0.4011896
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004749418	0.37995344
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.004749418	0.37995344
ETHANOLAMINOSIS	0.004749418	0.37995344
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004749418	0.37995344
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00472349	0.3778792
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00472349	0.3778792
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00472349	0.3778792
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00472349	0.3778792
TRANSKETOLASE DEFICIENCY	0.00472349	0.3778792
PITT-HOPKINS SYNDROME	0.00472349	0.3778792
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00472349	0.3778792
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00472349	0.3778792
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.00472349	0.3778792
14Q12 MICRODELETION SYNDROME	0.00472349	0.3778792
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00472349	0.3778792
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00472349	0.3778792
MUCOLIPIDOSIS TYPE IV	0.00472349	0.3778792
3P25.3 MICRODELETION SYNDROME	0.00472349	0.3778792
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00472349	0.3778792
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00472349	0.3778792
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00472349	0.3778792
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00472349	0.3778792
1P36 DELETION SYNDROME	0.00472349	0.3778792
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.00472349	0.3778792
ANGELMAN SYNDROME	0.00472349	0.3778792
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004458038000000001	0.3566430400000001
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004458038000000001	0.3566430400000001
MOWAT-WILSON SYNDROME; MOWS	0.004458038000000001	0.3566430400000001
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.004458038000000001	0.3566430400000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.004458038000000001	0.3566430400000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004458038000000001	0.3566430400000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004458038000000001	0.3566430400000001
PONTINE TEGMENTAL CAP DYSPLASIA	0.004458038000000001	0.3566430400000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004458038000000001	0.3566430400000001
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.004458038000000001	0.3566430400000001
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004458038000000001	0.3566430400000001
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.004458038000000001	0.3566430400000001
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004458038000000001	0.3566430400000001
ADENYLOSUCCINATE LYASE DEFICIENCY	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004458038000000001	0.3566430400000001
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004458038000000001	0.3566430400000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004458038000000001	0.3566430400000001
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004458038000000001	0.3566430400000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.004458038000000001	0.3566430400000001
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.004458038000000001	0.3566430400000001
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.004458038000000001	0.3566430400000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004458038000000001	0.3566430400000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004458038000000001	0.3566430400000001
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.004458038000000001	0.3566430400000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.004458038000000001	0.3566430400000001
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004458038000000001	0.3566430400000001
TEMPLE-BARAITSER SYNDROME	0.004458038000000001	0.3566430400000001
AICARDI-GOUTIERES SYNDROME 7	0.004458038000000001	0.3566430400000001
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004458038000000001	0.3566430400000001
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.004458038000000001	0.3566430400000001
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004458038000000001	0.3566430400000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.004458038000000001	0.3566430400000001
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004458038000000001	0.3566430400000001
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004458038000000001	0.3566430400000001
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004458038000000001	0.3566430400000001
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004458038000000001	0.3566430400000001
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004458038000000001	0.3566430400000001
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.004458038000000001	0.3566430400000001
RAYNAUD-CLAES SYNDROME; MRXSRC	0.004458038000000001	0.3566430400000001
AL-RAQAD SYNDROME; ARS	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.004458038000000001	0.3566430400000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004458038000000001	0.3566430400000001
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004458038000000001	0.3566430400000001
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004458038000000001	0.3566430400000001
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004458038000000001	0.3566430400000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004458038000000001	0.3566430400000001
JOUBERT SYNDROME 24	0.004458038000000001	0.3566430400000001
SALT-AND-PEPPER SYNDROME	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004458038000000001	0.3566430400000001
YOU-HOOVER-FONG SYNDROME; YHFS	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004458038000000001	0.3566430400000001
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.004458038000000001	0.3566430400000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004458038000000001	0.3566430400000001
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004458038000000001	0.3566430400000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.004458038000000001	0.3566430400000001
OPTIC ATROPHY 11; OPA11	0.004458038000000001	0.3566430400000001
IMMUNODEFICIENCY 49; IMD49	0.004458038000000001	0.3566430400000001
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.004458038000000001	0.3566430400000001
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.004458038000000001	0.3566430400000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004458038000000001	0.3566430400000001
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.004458038000000001	0.3566430400000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004458038000000001	0.3566430400000001
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.004458038000000001	0.3566430400000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004458038000000001	0.3566430400000001
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004458038000000001	0.3566430400000001
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.004458038000000001	0.3566430400000001
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.004458038000000001	0.3566430400000001
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004458038000000001	0.3566430400000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004458038000000001	0.3566430400000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004458038000000001	0.3566430400000001
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0040932880000000005	0.32746304000000004
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0040932880000000005	0.32746304000000004
KLEEFSTRA SYNDROME 2; KLEFS2	0.0040932880000000005	0.32746304000000004
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0040932880000000005	0.32746304000000004
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0040932880000000005	0.32746304000000004
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0040932880000000005	0.32746304000000004
CHROMOSOME 1P36 DELETION SYNDROME	0.0040932880000000005	0.32746304000000004
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0040932880000000005	0.32746304000000004
GALACTOSE EPIMERASE DEFICIENCY	0.0040932880000000005	0.32746304000000004
DUBOWITZ SYNDROME	0.0040932880000000005	0.32746304000000004
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0040932880000000005	0.32746304000000004
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0040932880000000005	0.32746304000000004
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0040932880000000005	0.32746304000000004
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0040932880000000005	0.32746304000000004
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0040932880000000005	0.32746304000000004
HYPERPROLINEMIA, TYPE I	0.0040932880000000005	0.32746304000000004
WEAVER SYNDROME	0.0040932880000000005	0.32746304000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0040932880000000005	0.32746304000000004
CHROMOSOME 9P DELETION SYNDROME	0.0040932880000000005	0.32746304000000004
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0040932880000000005	0.32746304000000004
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0040932880000000005	0.32746304000000004
WITTEVEEN-KOLK SYNDROME	0.0040932880000000005	0.32746304000000004
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0040932880000000005	0.32746304000000004
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0040932880000000005	0.32746304000000004
PELIZAEUS-MERZBACHER DISEASE	0.0040932880000000005	0.32746304000000004
MENTAL RETARDATION, X-LINKED 93	0.0040932880000000005	0.32746304000000004
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.30303040000000003
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.30303040000000003
HYPERPROGLUCAGONEMIA	0.00378788	0.30303040000000003
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.30303040000000003
HOOFT DISEASE	0.00378788	0.30303040000000003
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.30303040000000003
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.30303040000000003
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.30303040000000003
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.30303040000000003
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.30303040000000003
PARAOXONASE 1	0.00378788	0.30303040000000003
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.30303040000000003
PERRY SYNDROME	0.00378788	0.30303040000000003
GAPO SYNDROME; GAPOS	0.00378788	0.30303040000000003
PACMAN DYSPLASIA	0.00378788	0.30303040000000003
APOLIPOPROTEIN(A)	0.00378788	0.30303040000000003
OVARIAN CANCER	0.00378788	0.30303040000000003
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.30303040000000003
GLUTATHIONURIA	0.00378788	0.30303040000000003
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.30303040000000003
OSTEOMESOPYKNOSIS	0.00378788	0.30303040000000003
EPILEPSY-TELANGIECTASIA	0.00378788	0.30303040000000003
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.30303040000000003
MACULAR CORNEAL DYSTROPHY	0.00378788	0.30303040000000003
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.30303040000000003
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.30303040000000003
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.30303040000000003
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.30303040000000003
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.30303040000000003
CARBOXYLESTERASE 1	0.00378788	0.30303040000000003
ALKAPTONURIA	0.00378788	0.30303040000000003
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.30303040000000003
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.30303040000000003
CITRULLINE TRANSPORT DEFECT	0.00378788	0.30303040000000003
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.30303040000000003
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.30303040000000003
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.30303040000000003
CEPHALIN LIPIDOSIS	0.00378788	0.30303040000000003
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.30303040000000003
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.30303040000000003
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.30303040000000003
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.30303040000000003
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.30303040000000003
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.30303040000000003
AREDYLD	0.00378788	0.30303040000000003
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.30303040000000003
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.30303040000000003
DERMATOLEUKODYSTROPHY	0.00378788	0.30303040000000003
ZINC, ELEVATED PLASMA	0.00378788	0.30303040000000003
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.30303040000000003
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.30303040000000003
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.30303040000000003
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.30303040000000003
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00378788	0.30303040000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	0.30303040000000003
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.30303040000000003
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.30303040000000003
MYOPATHY, SPHEROID BODY	0.00378788	0.30303040000000003
BEETURIA	0.00378788	0.30303040000000003
SPINAL ARACHNOIDITIS	0.00378788	0.30303040000000003
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.30303040000000003
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.30303040000000003
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.30303040000000003
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.30303040000000003
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.30303040000000003
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.30303040000000003
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.30303040000000003
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.30303040000000003
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.30303040000000003
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.30303040000000003
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.30303040000000003
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.30303040000000003
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.30303040000000003
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.30303040000000003
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.30303040000000003
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.30303040000000003
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.30303040000000003
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00378788	0.30303040000000003
OSTEOGENIC SARCOMA	0.00378788	0.30303040000000003
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.30303040000000003
FLOOD FACTOR DEFICIENCY	0.00378788	0.30303040000000003
LARON SYNDROME	0.00378788	0.30303040000000003
PITUITARY DWARFISM IV	0.00378788	0.30303040000000003
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.30303040000000003
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.30303040000000003
REVESZ SYNDROME	0.00378788	0.30303040000000003
PROGESTERONE RESISTANCE	0.00378788	0.30303040000000003
46,XX GONADAL DYSGENESIS	0.00378788	0.30303040000000003
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.30303040000000003
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.30303040000000003
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.30303040000000003
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.30303040000000003
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.30303040000000003
CALVARIAL HYPEROSTOSIS	0.00378788	0.30303040000000003
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.30303040000000003
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.30303040000000003
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.30303040000000003
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.30303040000000003
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.30303040000000003
FINGERPRINT BODY MYOPATHY	0.00378788	0.30303040000000003
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.30303040000000003
BARTTER SYNDROME	0.00378788	0.30303040000000003
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.30303040000000003
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.30303040000000003
ICHTHYOSIS, X-LINKED	0.00378788	0.30303040000000003
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.30303040000000003
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.30303040000000003
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.30303040000000003
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.30303040000000003
PYGMY	0.00378788	0.30303040000000003
COUMARIN RESISTANCE	0.00378788	0.30303040000000003
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.30303040000000003
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.30303040000000003
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.30303040000000003
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.30303040000000003
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.30303040000000003
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.30303040000000003
PENDRED SYNDROME	0.00378788	0.30303040000000003
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.30303040000000003
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.30303040000000003
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.30303040000000003
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.30303040000000003
T-SUBSTANCE ANOMALY	0.00378788	0.30303040000000003
XANTHINURIA, TYPE I	0.00378788	0.30303040000000003
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.30303040000000003
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.30303040000000003
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.30303040000000003
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.30303040000000003
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.30303040000000003
ALAND ISLAND EYE DISEASE	0.00378788	0.30303040000000003
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.30303040000000003
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.30303040000000003
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.30303040000000003
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.30303040000000003
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.30303040000000003
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.30303040000000003
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.30303040000000003
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.30303040000000003
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.30303040000000003
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.30303040000000003
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.30303040000000003
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.30303040000000003
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.30303040000000003
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.30303040000000003
PREMATURE OVARIAN FAILURE 1	0.00378788	0.30303040000000003
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.30303040000000003
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.30303040000000003
ONCOCYTOMA	0.00378788	0.30303040000000003
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.30303040000000003
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.30303040000000003
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.30303040000000003
HEINZ BODY ANEMIAS	0.00378788	0.30303040000000003
TRISOMY 18-LIKE SYNDROME	0.00378788	0.30303040000000003
ACETYLATION, SLOW	0.00378788	0.30303040000000003
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.30303040000000003
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.30303040000000003
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.30303040000000003
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.30303040000000003
LIPASE DEFICIENCY, COMBINED	0.00378788	0.30303040000000003
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.30303040000000003
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.30303040000000003
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.30303040000000003
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.30303040000000003
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	0.30303040000000003
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.30303040000000003
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.30303040000000003
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.30303040000000003
SCHIZOPHRENIA 4	0.00378788	0.30303040000000003
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.30303040000000003
MACROCYTOSIS, FAMILIAL	0.00378788	0.30303040000000003
HYPOASCORBEMIA	0.00378788	0.30303040000000003
LYMPHOKINE DEFICIENCY	0.00378788	0.30303040000000003
GLOMUVENOUS MALFORMATIONS	0.00378788	0.30303040000000003
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.30303040000000003
GLUTATHIONE REDUCTASE	0.00378788	0.30303040000000003
NEPHROSIALIDOSIS	0.00378788	0.30303040000000003
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.30303040000000003
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.30303040000000003
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.30303040000000003
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.30303040000000003
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.30303040000000003
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.30303040000000003
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.30303040000000003
XM SYSTEM	0.00378788	0.30303040000000003
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.30303040000000003
DELETED IN AZOOSPERMIA	0.00378788	0.30303040000000003
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.30303040000000003
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.30303040000000003
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.30303040000000003
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.30303040000000003
GONADOBLASTOMA	0.00378788	0.30303040000000003
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.30303040000000003
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0034965000000000005	0.2797200000000001
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.2797200000000001
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0034965000000000005	0.2797200000000001
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0034965000000000005	0.2797200000000001
PITT-HOPKINS-LIKE SYNDROME	0.0034965000000000005	0.2797200000000001
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0034965000000000005	0.2797200000000001
HOLMES-GANG SYNDROME	0.0034965000000000005	0.2797200000000001
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0034965000000000005	0.2797200000000001
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034965000000000005	0.2797200000000001
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0034965000000000005	0.2797200000000001
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.2797200000000001
OLIVER SYNDROME	0.0034965000000000005	0.2797200000000001
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0034965000000000005	0.2797200000000001
CHROMOSOME 1P35 DELETION SYNDROME	0.0034965000000000005	0.2797200000000001
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0034965000000000005	0.2797200000000001
COFFIN-SIRIS SYNDROME 5	0.0034965000000000005	0.2797200000000001
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.2797200000000001
FOIX-CHAVANY-MARIE SYNDROME	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.2797200000000001
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.2797200000000001
CHILDHOOD DISINTEGRATIVE DISORDER	0.0034965000000000005	0.2797200000000001
LISSENCEPHALY 8; LIS8	0.0034965000000000005	0.2797200000000001
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0034965000000000005	0.2797200000000001
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.2797200000000001
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0034965000000000005	0.2797200000000001
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0034965000000000005	0.2797200000000001
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.2797200000000001
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.2797200000000001
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0034965000000000005	0.2797200000000001
AMISH INFANTILE EPILEPSY SYNDROME	0.0034965000000000005	0.2797200000000001
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0034965000000000005	0.2797200000000001
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0034965000000000005	0.2797200000000001
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0034965000000000005	0.2797200000000001
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0034965000000000005	0.2797200000000001
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 103	0.0034965000000000005	0.2797200000000001
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.2797200000000001
HALL-RIGGS SYNDROME	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.0034965000000000005	0.2797200000000001
GABRIELE-DE VRIES SYNDROME	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0034965000000000005	0.2797200000000001
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0034965000000000005	0.2797200000000001
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.0034965000000000005	0.2797200000000001
SCHAAF-YANG SYNDROME; SHFYNG	0.0034965000000000005	0.2797200000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0034965000000000005	0.2797200000000001
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0034965000000000005	0.2797200000000001
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0034965000000000005	0.2797200000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0034965000000000005	0.2797200000000001
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.2797200000000001
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0034965000000000005	0.2797200000000001
CHRISTIANSON SYNDROME	0.0034965000000000005	0.2797200000000001
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0034965000000000005	0.2797200000000001
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0034965000000000005	0.2797200000000001
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0034965000000000005	0.2797200000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.0034965000000000005	0.2797200000000001
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0034965000000000005	0.2797200000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0034965000000000005	0.2797200000000001
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.2797200000000001
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.2797200000000001
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.0034965000000000005	0.2797200000000001
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.0034965000000000005	0.2797200000000001
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.0034965000000000005	0.2797200000000001
PEHO-LIKE SYNDROME; PEHOL	0.0034965000000000005	0.2797200000000001
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.0034965000000000005	0.2797200000000001
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0034965000000000005	0.2797200000000001
XQ28 (MECP2) DUPLICATION	0.0034965000000000005	0.2797200000000001
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0034965000000000005	0.2797200000000001
19P13.3 MICRODUPLICATION SYNDROME	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0034965000000000005	0.2797200000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.0034965000000000005	0.2797200000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0034965000000000005	0.2797200000000001
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0034965000000000005	0.2797200000000001
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0034965000000000005	0.2797200000000001
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.2797200000000001
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0034965000000000005	0.2797200000000001
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0034965000000000005	0.2797200000000001
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0034965000000000005	0.2797200000000001
ALLAN-HERNDON-DUDLEY SYNDROME	0.0034965000000000005	0.2797200000000001
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0034965000000000005	0.2797200000000001
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0034965000000000005	0.2797200000000001
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.0034965000000000005	0.2797200000000001
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0034965000000000005	0.2797200000000001
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0034965000000000005	0.2797200000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0034965000000000005	0.2797200000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0034965000000000005	0.2797200000000001
INFANTILE DYSTONIA-PARKINSONISM	0.0034965000000000005	0.2797200000000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.0034965000000000005	0.2797200000000001
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.0034965000000000005	0.2797200000000001
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0034965000000000005	0.2797200000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0034965000000000005	0.2797200000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.2797200000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0034965000000000005	0.2797200000000001
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00313175	0.25054
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00313175	0.25054
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00313175	0.25054
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00313175	0.25054
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00313175	0.25054
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00313175	0.25054
2Q32Q33 MICRODELETION SYNDROME	0.00313175	0.25054
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00313175	0.25054
19P13.12 MICRODELETION SYNDROME	0.00313175	0.25054
2Q23.1 MICRODELETION SYNDROME	0.00313175	0.25054
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00313175	0.25054
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00313175	0.25054
5Q14.3 MICRODELETION SYNDROME	0.00313175	0.25054
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00313175	0.25054
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00313175	0.25054
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00313175	0.25054
HYPERLYSINEMIA, TYPE I	0.00313175	0.25054
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00313175	0.25054
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00313175	0.25054
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00313175	0.25054
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.00313175	0.25054
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00313175	0.25054
1Q44 MICRODELETION SYNDROME	0.00313175	0.25054
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00313175	0.25054
4Q21 MICRODELETION SYNDROME	0.00313175	0.25054
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00313175	0.25054
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00313175	0.25054
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00313175	0.25054
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00313175	0.25054
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00313175	0.25054
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00313175	0.25054
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00313175	0.25054
12Q14 MICRODELETION SYNDROME	0.00313175	0.25054
15Q11Q13 MICRODUPLICATION SYNDROME	0.00313175	0.25054
49,XYYYY SYNDROME	0.00313175	0.25054
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00313175	0.25054
MONOSOMY 18P	0.00313175	0.25054
6Q16 MICRODELETION SYNDROME	0.00313175	0.25054
KLEEFSTRA SYNDROME	0.00313175	0.25054
WIEDEMANN-STEINER SYNDROME	0.00313175	0.25054
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00313175	0.25054
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0028662979999999998	0.22930384
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0028662979999999998	0.22930384
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0028662979999999998	0.22930384
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0028662979999999998	0.22930384
COHEN-GIBSON SYNDROME; COGIS	0.0028662979999999998	0.22930384
AL KAISSI SYNDROME; ALKAS	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0028662979999999998	0.22930384
COFFIN-SIRIS SYNDROME 6; CSS6	0.0028662979999999998	0.22930384
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0028662979999999998	0.22930384
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0028662979999999998	0.22930384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0028662979999999998	0.22930384
JOUBERT SYNDROME 30; JBTS30	0.0028662979999999998	0.22930384
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0028662979999999998	0.22930384
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0028662979999999998	0.22930384
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0028662979999999998	0.22930384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0028662979999999998	0.22930384
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0028662979999999998	0.22930384
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0028662979999999998	0.22930384
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0028662979999999998	0.22930384
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028662979999999998	0.22930384
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0028662979999999998	0.22930384
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.0028662979999999998	0.22930384
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0028662979999999998	0.22930384
SOTOS SYNDROME 2	0.0028662979999999998	0.22930384
SHASHI-PENA SYNDROME; SHAPNS	0.0028662979999999998	0.22930384
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0028662979999999998	0.22930384
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0028662979999999998	0.22930384
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0028662979999999998	0.22930384
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0028662979999999998	0.22930384
SHUKLA-VERNON SYNDROME; SHUVER	0.0028662979999999998	0.22930384
SPINOCEREBELLAR ATAXIA TYPE 29	0.0028662979999999998	0.22930384
WIEACKER-WOLFF SYNDROME	0.0028662979999999998	0.22930384
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028662979999999998	0.22930384
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0028662979999999998	0.22930384
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0028662979999999998	0.22930384
HUNTINGTON DISEASE-LIKE 1	0.0028662979999999998	0.22930384
ADENYLOSUCCINASE DEFICIENCY	0.0028662979999999998	0.22930384
KLEEFSTRA SYNDROME	0.0028662979999999998	0.22930384
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0028662979999999998	0.22930384
KOOLEN-DE VRIES SYNDROME; KDVS	0.0028662979999999998	0.22930384
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0028662979999999998	0.22930384
SIALIDOSIS TYPE 2	0.0028662979999999998	0.22930384
NOONAN SYNDROME 6; NS6	0.0028662979999999998	0.22930384
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0028662979999999998	0.22930384
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0028662979999999998	0.22930384
XQ25 DUPLICATION SYNDROME	0.0028662979999999998	0.22930384
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0028662979999999998	0.22930384
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0028662979999999998	0.22930384
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0028662979999999998	0.22930384
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0028662979999999998	0.22930384
MICROTRIPLICATION 11Q24.1	0.0028662979999999998	0.22930384
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0028662979999999998	0.22930384
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0028662979999999998	0.22930384
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0028662979999999998	0.22930384
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0028662979999999998	0.22930384
2P15P16.1 MICRODELETION SYNDROME	0.0028662979999999998	0.22930384
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0028662979999999998	0.22930384
CK SYNDROME	0.0028662979999999998	0.22930384
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0028662979999999998	0.22930384
ALG13-CDG	0.0028662979999999998	0.22930384
EMANUEL SYNDROME	0.0028662979999999998	0.22930384
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0028662979999999998	0.22930384
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0028662979999999998	0.22930384
TETRASOMY 9P	0.0028662979999999998	0.22930384
MEHMO SYNDROME; MEHMO	0.0028662979999999998	0.22930384
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0028662979999999998	0.22930384
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0028662979999999998	0.22930384
MENTAL RETARDATION, X-LINKED 19	0.0028662979999999998	0.22930384
7Q11.23 MICRODUPLICATION SYNDROME	0.0028662979999999998	0.22930384
MENTAL RETARDATION, X-LINKED 90	0.0028662979999999998	0.22930384
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0028662979999999998	0.22930384
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0028662979999999998	0.22930384
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0028662979999999998	0.22930384
LAMB-SHAFFER SYNDROME	0.0028662979999999998	0.22930384
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0028662979999999998	0.22930384
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0028662979999999998	0.22930384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0028662979999999998	0.22930384
DESANTO-SHINAWI SYNDROME	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0028662979999999998	0.22930384
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0028662979999999998	0.22930384
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0028662979999999998	0.22930384
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0028662979999999998	0.22930384
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0028662979999999998	0.22930384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0028662979999999998	0.22930384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0028662979999999998	0.22930384
LUSCAN-LUMISH SYNDROME; LLS	0.0028662979999999998	0.22930384
COFFIN-SIRIS SYNDROME 7; CSS7	0.0028662979999999998	0.22930384
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028662979999999998	0.22930384
VERVERI-BRADY SYNDROME; VERBRAS	0.0028662979999999998	0.22930384
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0028662979999999998	0.22930384
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028662979999999998	0.22930384
CHITAYAT SYNDROME	0.0028662979999999998	0.22930384
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0028662979999999998	0.22930384
HAREL-YOON SYNDROME; HAYOS	0.0028662979999999998	0.22930384
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0028662979999999998	0.22930384
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0028662979999999998	0.22930384
TENORIO SYNDROME; TNORS	0.0028662979999999998	0.22930384
COFFIN-SIRIS SYNDROME 8; CSS8	0.0028662979999999998	0.22930384
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0028662979999999998	0.22930384
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0028662979999999998	0.22930384
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0028662979999999998	0.22930384
COFFIN-SIRIS SYNDROME 2; CSS2	0.0028662979999999998	0.22930384
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0028662979999999998	0.22930384
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0028662979999999998	0.22930384
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028662979999999998	0.22930384
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0028662979999999998	0.22930384
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028662979999999998	0.22930384
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0028662979999999998	0.22930384
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0028662979999999998	0.22930384
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0028662979999999998	0.22930384
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0028662979999999998	0.22930384
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0028662979999999998	0.22930384
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0028662979999999998	0.22930384
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028662979999999998	0.22930384
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0028662979999999998	0.22930384
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0028662979999999998	0.22930384
CAMPOMELIC DYSPLASIA	0.0021885280000000003	0.17508224000000003
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0021885280000000003	0.17508224000000003
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0021885280000000003	0.17508224000000003
ADAMS-OLIVER SYNDROME 1; AOS1	0.0021885280000000003	0.17508224000000003
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021885280000000003	0.17508224000000003
HYPOTONIA-CYSTINURIA SYNDROME	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0021885280000000003	0.17508224000000003
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0021885280000000003	0.17508224000000003
ZUNICH NEUROECTODERMAL SYNDROME	0.0021885280000000003	0.17508224000000003
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0021885280000000003	0.17508224000000003
LISSENCEPHALY, X-LINKED, 2	0.0021885280000000003	0.17508224000000003
LESCH-NYHAN SYNDROME; LNS	0.0021885280000000003	0.17508224000000003
ZIMMERMANN-LABAND SYNDROME 1	0.0021885280000000003	0.17508224000000003
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0021885280000000003	0.17508224000000003
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0021885280000000003	0.17508224000000003
NOONAN SYNDROME 7; NS7	0.0021885280000000003	0.17508224000000003
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0021885280000000003	0.17508224000000003
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0021885280000000003	0.17508224000000003
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.0021885280000000003	0.17508224000000003
COFFIN-LOWRY SYNDROME; CLS	0.0021885280000000003	0.17508224000000003
AICARDI SYNDROME; AIC	0.0021885280000000003	0.17508224000000003
CRANIOFRONTONASAL SYNDROME; CFNS	0.0021885280000000003	0.17508224000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0021885280000000003	0.17508224000000003
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0021885280000000003	0.17508224000000003
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0021885280000000003	0.17508224000000003
EPILEPSY, HOT WATER, 1	0.0021885280000000003	0.17508224000000003
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0021885280000000003	0.17508224000000003
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0021885280000000003	0.17508224000000003
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0021885280000000003	0.17508224000000003
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0021885280000000003	0.17508224000000003
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0021885280000000003	0.17508224000000003
GLYCOGEN STORAGE DISEASE IXC	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021885280000000003	0.17508224000000003
METACHROMATIC LEUKODYSTROPHY	0.0021885280000000003	0.17508224000000003
OROFACIODIGITAL SYNDROME VI	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0021885280000000003	0.17508224000000003
DESBUQUOIS DYSPLASIA 1	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0021885280000000003	0.17508224000000003
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0021885280000000003	0.17508224000000003
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0021885280000000003	0.17508224000000003
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0021885280000000003	0.17508224000000003
LEIGH SYNDROME; LS	0.0021885280000000003	0.17508224000000003
NEURAMINIDASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
ELEJALDE DISEASE	0.0021885280000000003	0.17508224000000003
NIEMANN-PICK DISEASE, TYPE A	0.0021885280000000003	0.17508224000000003
OPSISMODYSPLASIA; OPSMD	0.0021885280000000003	0.17508224000000003
OSTEOPENIA AND SPARSE HAIR	0.0021885280000000003	0.17508224000000003
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0021885280000000003	0.17508224000000003
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0021885280000000003	0.17508224000000003
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0021885280000000003	0.17508224000000003
FUMARASE DEFICIENCY; FMRD	0.0021885280000000003	0.17508224000000003
PEROXISOME BIOGENESIS DISORDER 3B	0.0021885280000000003	0.17508224000000003
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0021885280000000003	0.17508224000000003
INFANTILE SIALIC ACID STORAGE DISEASE	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0021885280000000003	0.17508224000000003
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0021885280000000003	0.17508224000000003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0021885280000000003	0.17508224000000003
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0021885280000000003	0.17508224000000003
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0021885280000000003	0.17508224000000003
CYCLIC VOMITING SYNDROME	0.0021885280000000003	0.17508224000000003
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0021885280000000003	0.17508224000000003
PORPHYRIA, ACUTE HEPATIC	0.0021885280000000003	0.17508224000000003
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0021885280000000003	0.17508224000000003
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0021885280000000003	0.17508224000000003
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0021885280000000003	0.17508224000000003
NEMALINE MYOPATHY 4	0.0021885280000000003	0.17508224000000003
SCHINDLER DISEASE, TYPE I	0.0021885280000000003	0.17508224000000003
PIERSON SYNDROME	0.0021885280000000003	0.17508224000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0021885280000000003	0.17508224000000003
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0021885280000000003	0.17508224000000003
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0021885280000000003	0.17508224000000003
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0021885280000000003	0.17508224000000003
BOHRING-OPITZ SYNDROME	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 3; JBTS3	0.0021885280000000003	0.17508224000000003
SPINOCEREBELLAR ATAXIA 13	0.0021885280000000003	0.17508224000000003
GLYCINE ENCEPHALOPATHY; GCE	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0021885280000000003	0.17508224000000003
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 2	0.0021885280000000003	0.17508224000000003
GENITOPATELLAR SYNDROME; GTPTS	0.0021885280000000003	0.17508224000000003
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0021885280000000003	0.17508224000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0021885280000000003	0.17508224000000003
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0021885280000000003	0.17508224000000003
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0021885280000000003	0.17508224000000003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0021885280000000003	0.17508224000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0021885280000000003	0.17508224000000003
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0021885280000000003	0.17508224000000003
WARBURG MICRO SYNDROME 1	0.0021885280000000003	0.17508224000000003
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0021885280000000003	0.17508224000000003
CODAS SYNDROME	0.0021885280000000003	0.17508224000000003
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 8	0.0021885280000000003	0.17508224000000003
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0021885280000000003	0.17508224000000003
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0021885280000000003	0.17508224000000003
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0021885280000000003	0.17508224000000003
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.0021885280000000003	0.17508224000000003
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0021885280000000003	0.17508224000000003
PALLISTER-KILLIAN SYNDROME	0.0021885280000000003	0.17508224000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 5	0.0021885280000000003	0.17508224000000003
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0021885280000000003	0.17508224000000003
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0021885280000000003	0.17508224000000003
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 6	0.0021885280000000003	0.17508224000000003
NEMALINE MYOPATHY 7; NEM7	0.0021885280000000003	0.17508224000000003
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0021885280000000003	0.17508224000000003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0021885280000000003	0.17508224000000003
MARSHALL-SMITH SYNDROME; MRSHSS	0.0021885280000000003	0.17508224000000003
MEVALONIC ACIDURIA; MEVA	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0021885280000000003	0.17508224000000003
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0021885280000000003	0.17508224000000003
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
PYRUVATE CARBOXYLASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.0021885280000000003	0.17508224000000003
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0021885280000000003	0.17508224000000003
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0021885280000000003	0.17508224000000003
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0021885280000000003	0.17508224000000003
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0021885280000000003	0.17508224000000003
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0021885280000000003	0.17508224000000003
ROIFMAN SYNDROME; RFMN	0.0021885280000000003	0.17508224000000003
C SYNDROME	0.0021885280000000003	0.17508224000000003
CRANIOSYNOSTOSIS 6; CRS6	0.0021885280000000003	0.17508224000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0021885280000000003	0.17508224000000003
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0021885280000000003	0.17508224000000003
SENGERS SYNDROME	0.0021885280000000003	0.17508224000000003
CEREBELLAR HYPOPLASIA	0.0021885280000000003	0.17508224000000003
JOUBERT SYNDROME 1	0.0021885280000000003	0.17508224000000003
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0021885280000000003	0.17508224000000003
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0021885280000000003	0.17508224000000003
GRISCELLI SYNDROME, TYPE 1	0.0021885280000000003	0.17508224000000003
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021885280000000003	0.17508224000000003
COACH SYNDROME	0.0021885280000000003	0.17508224000000003
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0021885280000000003	0.17508224000000003
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0021885280000000003	0.17508224000000003
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0021885280000000003	0.17508224000000003
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0021885280000000003	0.17508224000000003
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0021885280000000003	0.17508224000000003
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0021885280000000003	0.17508224000000003
RITSCHER-SCHINZEL SYNDROME 1	0.0021885280000000003	0.17508224000000003
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0021885280000000003	0.17508224000000003
KABUKI SYNDROME 1	0.0021885280000000003	0.17508224000000003
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0021885280000000003	0.17508224000000003
HOLOPROSENCEPHALY 2; HPE2	0.0021885280000000003	0.17508224000000003
MYOTONIC DYSTROPHY 1	0.0021885280000000003	0.17508224000000003
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.0021885280000000003	0.17508224000000003
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0021885280000000003	0.17508224000000003
SHPRINTZEN OMPHALOCELE SYNDROME	0.0021885280000000003	0.17508224000000003
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0021885280000000003	0.17508224000000003
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0021885280000000003	0.17508224000000003
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0021885280000000003	0.17508224000000003
WILLIAMS-BEUREN SYNDROME; WBS	0.0021885280000000003	0.17508224000000003
ACID PHOSPHATASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.17508224000000003
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0021885280000000003	0.17508224000000003
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
MICROPHTHALMIA, SYNDROMIC 3	0.0021885280000000003	0.17508224000000003
CHIARI MALFORMATION TYPE II	0.0021885280000000003	0.17508224000000003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0021885280000000003	0.17508224000000003
ARTERIAL TORTUOSITY SYNDROME	0.0021885280000000003	0.17508224000000003
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0021885280000000003	0.17508224000000003
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0021885280000000003	0.17508224000000003
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0021885280000000003	0.17508224000000003
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021885280000000003	0.17508224000000003
MAPLE SYRUP URINE DISEASE; MSUD	0.0021885280000000003	0.17508224000000003
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0021885280000000003	0.17508224000000003
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0021885280000000003	0.17508224000000003
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0021885280000000003	0.17508224000000003
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0021885280000000003	0.17508224000000003
HYPOPHOSPHATASIA, INFANTILE	0.0021885280000000003	0.17508224000000003
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0021885280000000003	0.17508224000000003
VICI SYNDROME; VICIS	0.0021885280000000003	0.17508224000000003
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0021885280000000003	0.17508224000000003
GLYCOGEN STORAGE DISEASE II	0.0021885280000000003	0.17508224000000003
KETOADIPICACIDURIA	0.0021885280000000003	0.17508224000000003
VISCERAL STEATOSIS, CONGENITAL	0.0021885280000000003	0.17508224000000003
ARIMA SYNDROME	0.0021885280000000003	0.17508224000000003
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0021885280000000003	0.17508224000000003
JOHANSON-BLIZZARD SYNDROME; JBS	0.0021885280000000003	0.17508224000000003
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0021885280000000003	0.17508224000000003
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0021885280000000003	0.17508224000000003
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0021885280000000003	0.17508224000000003
GLUTARIC ACIDEMIA I; GA1	0.0021885280000000003	0.17508224000000003
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0021885280000000003	0.17508224000000003
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0021885280000000003	0.17508224000000003
MARDEN-WALKER SYNDROME	0.0021885280000000003	0.17508224000000003
GLYCOGEN STORAGE DISEASE IV	0.0021885280000000003	0.17508224000000003
OHDO SYNDROME	0.0021885280000000003	0.17508224000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021885280000000003	0.17508224000000003
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	0.1523808
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.1523808
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.1523808
AUTISM	0.00190476	0.1523808
8P23.1 DUPLICATION SYNDROME	0.00190476	0.1523808
NAGER SYNDROME	0.00190476	0.1523808
EPISODIC ATAXIA TYPE 1	0.00190476	0.1523808
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	0.1523808
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.1523808
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	0.1523808
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.1523808
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.1523808
MASA SYNDROME	0.00190476	0.1523808
WRINKLY SKIN SYNDROME	0.00190476	0.1523808
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.1523808
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.1523808
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	0.1523808
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.1523808
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.00190476	0.1523808
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.1523808
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.1523808
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.1523808
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.1523808
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.1523808
LIG4 SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	0.1523808
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.1523808
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00190476	0.1523808
1P21.3 MICRODELETION SYNDROME	0.00190476	0.1523808
TEMPLE SYNDROME	0.00190476	0.1523808
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.1523808
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.1523808
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00190476	0.1523808
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.1523808
DE BARSY SYNDROME	0.00190476	0.1523808
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.1523808
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00190476	0.1523808
3Q29 MICRODELETION SYNDROME	0.00190476	0.1523808
LANDAU-KLEFFNER SYNDROME	0.00190476	0.1523808
11P15.4 MICRODUPLICATION SYNDROME	0.00190476	0.1523808
DIGEORGE SYNDROME; DGS	0.00190476	0.1523808
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.1523808
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.1523808
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00190476	0.1523808
15Q14 MICRODELETION SYNDROME	0.00190476	0.1523808
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, X-LINKED 9	0.00190476	0.1523808
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.1523808
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.00190476	0.1523808
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00190476	0.1523808
MILD CANAVAN DISEASE	0.00190476	0.1523808
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00190476	0.1523808
COG5-CDG	0.00190476	0.1523808
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00190476	0.1523808
BARATELA-SCOTT SYNDROME	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00190476	0.1523808
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.1523808
DISTAL TRISOMY 5Q	0.00190476	0.1523808
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	0.1523808
DUCHENNE MUSCULAR DYSTROPHY	0.00190476	0.1523808
DISTAL MONOSOMY 6P	0.00190476	0.1523808
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.1523808
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.1523808
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00190476	0.1523808
EPIDERMAL NEVUS SYNDROME	0.00190476	0.1523808
49,XXXYY SYNDROME	0.00190476	0.1523808
FG SYNDROME 2; FGS2	0.00190476	0.1523808
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.1523808
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.1523808
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00190476	0.1523808
7P22.1 MICRODUPLICATION SYNDROME	0.00190476	0.1523808
FG SYNDROME TYPE 1	0.00190476	0.1523808
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.1523808
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.1523808
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	0.1523808
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.1523808
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.1523808
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00190476	0.1523808
SMITH-FINEMAN-MYERS SYNDROME	0.00190476	0.1523808
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	0.1523808
16P13.11 MICRODELETION SYNDROME	0.00190476	0.1523808
20Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.1523808
PARTINGTON SYNDROME	0.00190476	0.1523808
16Q24.3 MICRODELETION SYNDROME	0.00190476	0.1523808
CLEFT LIP/PALATE	0.00190476	0.1523808
17Q12 MICRODUPLICATION SYNDROME	0.00190476	0.1523808
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.1523808
DISTAL MONOSOMY 10Q	0.00190476	0.1523808
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.1523808
SAY-BARBER-MILLER SYNDROME	0.00190476	0.1523808
OKAMOTO SYNDROME	0.00190476	0.1523808
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.1523808
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.1523808
20P13 MICRODELETION SYNDROME	0.00190476	0.1523808
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00190476	0.1523808
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00190476	0.1523808
UNILATERAL POLYMICROGYRIA	0.00190476	0.1523808
BILATERAL POLYMICROGYRIA	0.00190476	0.1523808
20Q13.33 MICRODELETION SYNDROME	0.00190476	0.1523808
HSD10 DISEASE	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.1523808
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00190476	0.1523808
CORNELIA DE LANGE SYNDROME 1	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00190476	0.1523808
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.1523808
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00190476	0.1523808
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	0.1523808
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	0.1523808
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	0.1523808
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00190476	0.1523808
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	0.1523808
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	0.1523808
SAUL-WILSON SYNDROME; SWILS	0.00190476	0.1523808
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00190476	0.1523808
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	0.1523808
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.00190476	0.1523808
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.1523808
MICROTIA	0.00190476	0.1523808
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00190476	0.1523808
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	0.1523808
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.1523808
17Q24.2 MICRODELETION SYNDROME	0.00190476	0.1523808
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	0.1523808
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00190476	0.1523808
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00190476	0.1523808
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00190476	0.1523808
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	0.1523808
GENITOPATELLAR SYNDROME	0.00190476	0.1523808
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	0.1523808
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	0.1523808
9Q21.13 MICRODELETION SYNDROME	0.00190476	0.1523808
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00190476	0.1523808
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00190476	0.1523808
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00190476	0.1523808
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.1523808
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.1523808
MEIER-GORLIN SYNDROME 6; MGORS6	0.00190476	0.1523808
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	0.1523808
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.1523808
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.1523808
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	0.1523808
ASPARTYLGLUCOSAMINURIA	0.00190476	0.1523808
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.1523808
CHROMOSOME 17Q12 DELETION SYNDROME	0.00190476	0.1523808
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	0.1523808
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00190476	0.1523808
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00190476	0.1523808
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	0.1523808
11Q22.2Q22.3 MICRODELETION SYNDROME	0.00190476	0.1523808
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00190476	0.1523808
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.1523808
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	0.1523808
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00190476	0.1523808
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.1523808
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.1523808
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.1523808
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.1523808
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00190476	0.1523808
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	0.1523808
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	0.1523808
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00190476	0.1523808
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.1523808
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00190476	0.1523808
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.1523808
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00190476	0.1523808
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00190476	0.1523808
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.1523808
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00190476	0.1523808
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	0.1523808
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.1523808
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.1523808
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.1523808
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00190476	0.1523808
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00190476	0.1523808
ACERULOPLASMINEMIA	0.00190476	0.1523808
CRANIOSYNOSTOSIS 7	0.00190476	0.1523808
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.1523808
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.1523808
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00190476	0.1523808
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00190476	0.1523808
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00190476	0.1523808
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.1523808
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.1523808
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	0.1523808
ADNP SYNDROME	0.00190476	0.1523808
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00190476	0.1523808
3Q27.3 MICRODELETION SYNDROME	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.1523808
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.1523808
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.1523808
ABLEPHARON MACROSTOMIA SYNDROME	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	0.1523808
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.1523808
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00190476	0.1523808
DISTAL MONOSOMY 15Q	0.00190476	0.1523808
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.1523808
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.1523808
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	0.1523808
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00190476	0.1523808
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	0.1523808
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00190476	0.1523808
6Q TERMINAL DELETION SYNDROME	0.00190476	0.1523808
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	0.1523808
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	0.1523808
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.1523808
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.1523808
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00190476	0.1523808
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	0.1523808
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00190476	0.1523808
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.1523808
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00190476	0.1523808
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.1523808
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	0.1523808
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	0.1523808
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00190476	0.1523808
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.1523808
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00190476	0.1523808
GLASS SYNDROME	0.00190476	0.1523808
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.1523808
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.1523808
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00190476	0.1523808
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00190476	0.1523808
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.00190476	0.1523808
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.1523808
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	0.1523808
DYSTONIA 16; DYT16	0.00190476	0.1523808
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.1523808
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00190476	0.1523808
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.1523808
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00190476	0.1523808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00190476	0.1523808
PEARSON SYNDROME	0.00122699	0.09815920000000002
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00122699	0.09815920000000002
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.09815920000000002
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00122699	0.09815920000000002
ALPERS-HUTTENLOCHER SYNDROME	0.00122699	0.09815920000000002
POLYMYOSITIS	0.00122699	0.09815920000000002
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.09815920000000002
3C SYNDROME	0.00122699	0.09815920000000002
MOEBIUS SYNDROME	0.00122699	0.09815920000000002
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00122699	0.09815920000000002
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.09815920000000002
MENKES DISEASE	0.00122699	0.09815920000000002
MARFAN SYNDROME	0.00122699	0.09815920000000002
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00122699	0.09815920000000002
MELAS	0.00122699	0.09815920000000002
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.09815920000000002
BENIGN FAMILIAL INFANTILE EPILEPSY	0.00122699	0.09815920000000002
MAPLE SYRUP URINE DISEASE	0.00122699	0.09815920000000002
JOUBERT SYNDROME	0.00122699	0.09815920000000002
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00122699	0.09815920000000002
ONDINE SYNDROME	0.00122699	0.09815920000000002
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00122699	0.09815920000000002
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.00122699	0.09815920000000002
LEIGH SYNDROME	0.00122699	0.09815920000000002
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00122699	0.09815920000000002
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.09815920000000002
AICARDI SYNDROME	0.00122699	0.09815920000000002
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00122699	0.09815920000000002
KALLMANN SYNDROME	0.00122699	0.09815920000000002
AMISH LETHAL MICROCEPHALY	0.00122699	0.09815920000000002
ALEXANDER DISEASE	0.00122699	0.09815920000000002
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.09815920000000002
MUSCLE-EYE-BRAIN DISEASE	0.00122699	0.09815920000000002
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00122699	0.09815920000000002
LEBER CONGENITAL AMAUROSIS	0.00122699	0.09815920000000002
NOONAN SYNDROME	0.00122699	0.09815920000000002
LATHOSTEROLOSIS	0.00122699	0.09815920000000002
INCONTINENTIA PIGMENTI	0.00122699	0.09815920000000002
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00122699	0.09815920000000002
DIASTROPHIC DWARFISM	0.00122699	0.09815920000000002
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00122699	0.09815920000000002
ALPHA-MANNOSIDOSIS	0.00122699	0.09815920000000002
SEVERE CANAVAN DISEASE	0.00122699	0.09815920000000002
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.09815920000000002
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.09815920000000002
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00122699	0.09815920000000002
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.09815920000000002
CENTRAL CORE DISEASE	0.00122699	0.09815920000000002
X-LINKED CENTRONUCLEAR MYOPATHY	0.00122699	0.09815920000000002
CENTRONUCLEAR MYOPATHY	0.00122699	0.09815920000000002
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.00122699	0.09815920000000002
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00122699	0.09815920000000002
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
THYROID HYPOPLASIA	0.00122699	0.09815920000000002
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00122699	0.09815920000000002
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.00122699	0.09815920000000002
DPAGT1-CDG	0.00122699	0.09815920000000002
CONGENITAL TOXOPLASMOSIS	0.00122699	0.09815920000000002
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.00122699	0.09815920000000002
FRIED SYNDROME	0.00122699	0.09815920000000002
CONO-SPONDYLAR DYSPLASIA	0.00122699	0.09815920000000002
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00122699	0.09815920000000002
PHACE SYNDROME	0.00122699	0.09815920000000002
OROFACIODIGITAL SYNDROME TYPE 14	0.00122699	0.09815920000000002
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00122699	0.09815920000000002
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00122699	0.09815920000000002
MEHMO SYNDROME	0.00122699	0.09815920000000002
HYPOPHOSPHATASIA	0.00122699	0.09815920000000002
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00122699	0.09815920000000002
ACUTE ADRENAL INSUFFICIENCY	0.00122699	0.09815920000000002
FETAL GAUCHER DISEASE	0.00122699	0.09815920000000002
IMAGE SYNDROME	0.00122699	0.09815920000000002
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.00122699	0.09815920000000002
THYROID ECTOPIA	0.00122699	0.09815920000000002
ATHYREOSIS	0.00122699	0.09815920000000002
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00122699	0.09815920000000002
FAMILIAL THYROID DYSHORMONOGENESIS	0.00122699	0.09815920000000002
GAUCHER DISEASE	0.00122699	0.09815920000000002
GM1 GANGLIOSIDOSIS	0.00122699	0.09815920000000002
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00122699	0.09815920000000002
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00122699	0.09815920000000002
PERMANENT NEONATAL DIABETES MELLITUS	0.00122699	0.09815920000000002
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00122699	0.09815920000000002
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.09815920000000002
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.09815920000000002
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00122699	0.09815920000000002
FRAGILE X SYNDROME	0.00122699	0.09815920000000002
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.09815920000000002
THANATOPHORIC DYSPLASIA TYPE 2	0.00122699	0.09815920000000002
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.09815920000000002
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00122699	0.09815920000000002
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00122699	0.09815920000000002
SPONASTRIME DYSPLASIA	0.00122699	0.09815920000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00122699	0.09815920000000002
GOLDENHAR SYNDROME	0.00122699	0.09815920000000002
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00122699	0.09815920000000002
HURLER SYNDROME	0.00122699	0.09815920000000002
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.09815920000000002
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00122699	0.09815920000000002
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00122699	0.09815920000000002
WALKER-WARBURG SYNDROME	0.00122699	0.09815920000000002
HADDAD SYNDROME	0.00122699	0.09815920000000002
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00122699	0.09815920000000002
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00122699	0.09815920000000002
JUVENILE DERMATOMYOSITIS	0.00122699	0.09815920000000002
TETRASOMY 12P	0.00122699	0.09815920000000002
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00122699	0.09815920000000002
TRIPLE A SYNDROME	0.00122699	0.09815920000000002
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00122699	0.09815920000000002
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00122699	0.09815920000000002
THYROID HEMIAGENESIS	0.00122699	0.09815920000000002
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00122699	0.09815920000000002
TAY-SACHS DISEASE	0.00122699	0.09815920000000002
KOOLEN-DE VRIES SYNDROME	0.00122699	0.09815920000000002
FAMILIAL COLORECTAL CANCER TYPE X	0.00122699	0.09815920000000002
CONGENITAL HYPOTHYROIDISM	0.00122699	0.09815920000000002
L-2-HYDROXYGLUTARIC ACIDURIA	0.00122699	0.09815920000000002
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00122699	0.09815920000000002
20Q11.2 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00122699	0.09815920000000002
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00122699	0.09815920000000002
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00122699	0.09815920000000002
BIOTINIDASE DEFICIENCY	0.00122699	0.09815920000000002
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00122699	0.09815920000000002
ADRENOMYODYSTROPHY	0.00122699	0.09815920000000002
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00122699	0.09815920000000002
GALACTOSE EPIMERASE DEFICIENCY	0.00122699	0.09815920000000002
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.09815920000000002
FILIPPI SYNDROME	0.00122699	0.09815920000000002
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00122699	0.09815920000000002
MONOSOMY 9Q22.3	0.00122699	0.09815920000000002
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.09815920000000002
INFANTILE REFSUM DISEASE	0.00122699	0.09815920000000002
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00122699	0.09815920000000002
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00122699	0.09815920000000002
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.09815920000000002
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.09815920000000002
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.09815920000000002
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.00122699	0.09815920000000002
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00122699	0.09815920000000002
ALG6-CDG	0.00122699	0.09815920000000002
ALG3-CDG	0.00122699	0.09815920000000002
ERMINE PHENOTYPE	0.00122699	0.09815920000000002
SIALIDOSIS TYPE 1	0.00122699	0.09815920000000002
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00122699	0.09815920000000002
CAMOS SYNDROME	0.00122699	0.09815920000000002
DISTAL MONOSOMY 19P13.3	0.00122699	0.09815920000000002
GALACTOSEMIA	0.00122699	0.09815920000000002
FREE SIALIC ACID STORAGE DISEASE	0.00122699	0.09815920000000002
INFANTILE NEUROAXONAL DYSTROPHY	0.00122699	0.09815920000000002
FUCOSIDOSIS	0.00122699	0.09815920000000002
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00122699	0.09815920000000002
STICKLER SYNDROME	0.00122699	0.09815920000000002
ISOLATED SPINA BIFIDA	0.00122699	0.09815920000000002
SMITH-LEMLI-OPITZ SYNDROME	0.00122699	0.09815920000000002
SJÖGREN-LARSSON SYNDROME	0.00122699	0.09815920000000002
TRISOMY 18	0.00122699	0.09815920000000002
DPM1-CDG	0.00122699	0.09815920000000002
TRISOMY 13	0.00122699	0.09815920000000002
ANTISYNTHETASE SYNDROME	0.00122699	0.09815920000000002
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00122699	0.09815920000000002
TRISOMY X	0.00122699	0.09815920000000002
TRANSIENT NEONATAL DIABETES MELLITUS	0.00122699	0.09815920000000002
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.00122699	0.09815920000000002
B4GALT1-CDG	0.00122699	0.09815920000000002
ARTERIAL TORTUOSITY SYNDROME	0.00122699	0.09815920000000002
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00122699	0.09815920000000002
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00122699	0.09815920000000002
ALG9-CDG	0.00122699	0.09815920000000002
MPDU1-CDG	0.00122699	0.09815920000000002
KEARNS-SAYRE SYNDROME	0.00122699	0.09815920000000002
WOLF-HIRSCHHORN SYNDROME	0.00122699	0.09815920000000002
CONGENITAL RUBELLA SYNDROME	0.00122699	0.09815920000000002
THAKKER-DONNAI SYNDROME	0.00122699	0.09815920000000002
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00122699	0.09815920000000002
DYSEQUILIBRIUM SYNDROME	0.00122699	0.09815920000000002
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00122699	0.09815920000000002
CARTILAGE-HAIR HYPOPLASIA	0.00122699	0.09815920000000002
TRISOMY 4P	0.00122699	0.09815920000000002
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00122699	0.09815920000000002
KRABBE DISEASE	0.00122699	0.09815920000000002
DISTAL TRISOMY 15Q	0.00122699	0.09815920000000002
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00122699	0.09815920000000002
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.09815920000000002
NATIVE AMERICAN MYOPATHY	0.00122699	0.09815920000000002
WOLCOTT-RALLISON SYNDROME	0.00122699	0.09815920000000002
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.00122699	0.09815920000000002
DENT DISEASE	0.00122699	0.09815920000000002
DISTAL MONOSOMY 9P	0.00122699	0.09815920000000002
2P21 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
HYPOTONIA-CYSTINURIA SYNDROME	0.00122699	0.09815920000000002
3Q13 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
DISTAL MONOSOMY 3P	0.00122699	0.09815920000000002
MONOSOMY 13Q14	0.00122699	0.09815920000000002
NON-DISTAL MONOSOMY 10Q	0.00122699	0.09815920000000002
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00122699	0.09815920000000002
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00122699	0.09815920000000002
FAMILIAL BENIGN COPPER DEFICIENCY	0.00122699	0.09815920000000002
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.09815920000000002
INFANT BOTULISM	0.00122699	0.09815920000000002
ACHONDROPLASIA	0.00122699	0.09815920000000002
INTESTINAL BOTULISM	0.00122699	0.09815920000000002
GERODERMA OSTEODYSPLASTICA	0.00122699	0.09815920000000002
GERMAN SYNDROME	0.00122699	0.09815920000000002
FRYNS-SMEETS-THIRY SYNDROME	0.00122699	0.09815920000000002
COLE-CARPENTER SYNDROME	0.00122699	0.09815920000000002
CRIGLER-NAJJAR SYNDROME	0.00122699	0.09815920000000002
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00122699	0.09815920000000002
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00122699	0.09815920000000002
ACROCARDIOFACIAL SYNDROME	0.00122699	0.09815920000000002
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.00122699	0.09815920000000002
OCCIPITAL HORN SYNDROME	0.00122699	0.09815920000000002
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00122699	0.09815920000000002
CAT-EYE SYNDROME	0.00122699	0.09815920000000002
EARLY MYOCLONIC ENCEPHALOPATHY	0.00122699	0.09815920000000002
COHEN SYNDROME	0.00122699	0.09815920000000002
TOLUENE EMBRYOPATHY	0.00122699	0.09815920000000002
COFFIN-LOWRY SYNDROME	0.00122699	0.09815920000000002
FETAL METHYLMERCURY SYNDROME	0.00122699	0.09815920000000002
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00122699	0.09815920000000002
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.09815920000000002
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.09815920000000002
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.09815920000000002
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00122699	0.09815920000000002
THANATOPHORIC DYSPLASIA TYPE 1	0.00122699	0.09815920000000002
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.09815920000000002
KYPHOMELIC DYSPLASIA	0.00122699	0.09815920000000002
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.09815920000000002
VICI SYNDROME	0.00122699	0.09815920000000002
HARTNUP DISEASE	0.00122699	0.09815920000000002
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00122699	0.09815920000000002
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00122699	0.09815920000000002
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.09815920000000002
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00122699	0.09815920000000002
2Q37 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
LISSENCEPHALY 2; LIS2	0.00122699	0.09815920000000002
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.00122699	0.09815920000000002
CANAVAN DISEASE	0.00122699	0.09815920000000002
WAARDENBURG-SHAH SYNDROME	0.00122699	0.09815920000000002
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00122699	0.09815920000000002
POTOCKI-SHAFFER SYNDROME	0.00122699	0.09815920000000002
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00122699	0.09815920000000002
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00122699	0.09815920000000002
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
PRADER-WILLI SYNDROME (TYPE 1)	0.00122699	0.09815920000000002
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.09815920000000002
MACS SYNDROME	0.00122699	0.09815920000000002
MEVALONIC ACIDURIA	0.00122699	0.09815920000000002
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.09815920000000002
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.00122699	0.09815920000000002
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.09815920000000002
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.09815920000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00122699	0.09815920000000002
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.09815920000000002
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00122699	0.09815920000000002
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.09815920000000002
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
COOPER-JABS SYNDROME	0.00122699	0.09815920000000002
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00122699	0.09815920000000002
MULTIPLE CARBOXYLASE DEFICIENCY	0.00122699	0.09815920000000002
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.00122699	0.09815920000000002
COFFIN-SIRIS SYNDROME	0.00122699	0.09815920000000002
CODAS SYNDROME	0.00122699	0.09815920000000002
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00122699	0.09815920000000002
LYNCH SYNDROME	0.00122699	0.09815920000000002
RING CHROMOSOME 10 SYNDROME	0.00122699	0.09815920000000002
CANAVAN DISEASE	0.00122699	0.09815920000000002
ABETALIPOPROTEINEMIA	0.00122699	0.09815920000000002
ISOLATED CEREBELLAR AGENESIS	0.00122699	0.09815920000000002
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00122699	0.09815920000000002
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00122699	0.09815920000000002
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00122699	0.09815920000000002
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00122699	0.09815920000000002
CAREY-FINEMAN-ZITER SYNDROME	0.00122699	0.09815920000000002
CARDIOFACIOCUTANEOUS SYNDROME	0.00122699	0.09815920000000002
BETA-KETOTHIOLASE DEFICIENCY	0.00122699	0.09815920000000002
LAMBERT SYNDROME	0.00122699	0.09815920000000002
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.09815920000000002
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.09815920000000002
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00122699	0.09815920000000002
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00122699	0.09815920000000002
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.09815920000000002
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.09815920000000002
GRANT SYNDROME	0.00122699	0.09815920000000002
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00122699	0.09815920000000002
HAWKINSINURIA	0.00122699	0.09815920000000002
6P22 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00122699	0.09815920000000002
NEUROFACIODIGITORENAL SYNDROME	0.00122699	0.09815920000000002
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.09815920000000002
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00122699	0.09815920000000002
THANATOPHORIC DYSPLASIA	0.00122699	0.09815920000000002
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00122699	0.09815920000000002
14Q22Q23 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00122699	0.09815920000000002
XQ27.3Q28 DUPLICATION SYNDROME	0.00122699	0.09815920000000002
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
TRISOMY 20P	0.00122699	0.09815920000000002
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
20P12.3 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
TRISOMY 17P	0.00122699	0.09815920000000002
LINEAR NEVUS SEBACEUS SYNDROME	0.00122699	0.09815920000000002
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
MONOSOMY 9P	0.00122699	0.09815920000000002
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.09815920000000002
ISOLATED COMPLEX I DEFICIENCY	0.00122699	0.09815920000000002
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00122699	0.09815920000000002
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.09815920000000002
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00122699	0.09815920000000002
THANATOPHORIC DYSPLASIA, TYPE I	0.00122699	0.09815920000000002
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.09815920000000002
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00122699	0.09815920000000002
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.09815920000000002
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00122699	0.09815920000000002
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00122699	0.09815920000000002
XP22.13P22.2 DUPLICATION SYNDROME	0.00122699	0.09815920000000002
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00122699	0.09815920000000002
1P36 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.09815920000000002
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00122699	0.09815920000000002
PIEBALDISM	0.00122699	0.09815920000000002
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.09815920000000002
PRADER-WILLI SYNDROME (TYPE 2)	0.00122699	0.09815920000000002
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
NEONATAL MARFAN SYNDROME	0.00122699	0.09815920000000002
PERLMAN SYNDROME	0.00122699	0.09815920000000002
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00122699	0.09815920000000002
8Q21.11 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
STEINERT MYOTONIC DYSTROPHY	0.00122699	0.09815920000000002
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00122699	0.09815920000000002
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.00122699	0.09815920000000002
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00122699	0.09815920000000002
WOLF-HIRSCHHORN SYNDROME	0.00122699	0.09815920000000002
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00122699	0.09815920000000002
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00122699	0.09815920000000002
15Q13.3 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
LATERAL MENINGOCELE SYNDROME	0.00122699	0.09815920000000002
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00122699	0.09815920000000002
SMITH-MAGENIS SYNDROME	0.00122699	0.09815920000000002
OPSISMODYSPLASIA	0.00122699	0.09815920000000002
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00122699	0.09815920000000002
MONOSOMY 5P	0.00122699	0.09815920000000002
3Q29 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00122699	0.09815920000000002
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.09815920000000002
ISOTRETINOIN SYNDROME	0.00122699	0.09815920000000002
INFANTILE SYSTEMIC HYALINOSIS	0.00122699	0.09815920000000002
JOUBERT SYNDROME WITH RENAL DEFECT	0.00122699	0.09815920000000002
8Q12 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00122699	0.09815920000000002
HOLOPROSENCEPHALY	0.00122699	0.09815920000000002
2Q31.1 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00122699	0.09815920000000002
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00122699	0.09815920000000002
JOHANSON-BLIZZARD SYNDROME	0.00122699	0.09815920000000002
DERMATOMYOSITIS	0.00122699	0.09815920000000002
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00122699	0.09815920000000002
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00122699	0.09815920000000002
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.09815920000000002
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.09815920000000002
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.09815920000000002
MOWAT-WILSON SYNDROME	0.00122699	0.09815920000000002
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00122699	0.09815920000000002
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.09815920000000002
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.09815920000000002
17P13.3 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
17Q21.31 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00122699	0.09815920000000002
CITRULLINEMIA TYPE I	0.00122699	0.09815920000000002
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00122699	0.09815920000000002
MATTHEW-WOOD SYNDROME	0.00122699	0.09815920000000002
VELOCARDIOFACIAL SYNDROME	0.00122699	0.09815920000000002
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.09815920000000002
MARDEN-WALKER SYNDROME	0.00122699	0.09815920000000002
SHPRINTZEN-GOLDBERG SYNDROME	0.00122699	0.09815920000000002
RFT1-CDG	0.00122699	0.09815920000000002
LAURIN-SANDROW SYNDROME	0.00122699	0.09815920000000002
KABUKI SYNDROME	0.00122699	0.09815920000000002
1Q21.1 MICRODUPLICATION SYNDROME	0.00122699	0.09815920000000002
JUNG SYNDROME	0.00122699	0.09815920000000002
1Q21.1 MICRODELETION SYNDROME	0.00122699	0.09815920000000002
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0009615380000000001	0.07692304
COHEN SYNDROME	0.0009615380000000001	0.07692304
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0009615380000000001	0.07692304
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.07692304
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.07692304
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0009615380000000001	0.07692304
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0009615380000000001	0.07692304
ADAMS-OLIVER SYNDROME 2; AOS2	0.0009615380000000001	0.07692304
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.0009615380000000001	0.07692304
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0009615380000000001	0.07692304
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0009615380000000001	0.07692304
SHWACHMAN-DIAMOND SYNDROME	0.0009615380000000001	0.07692304
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.07692304
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0009615380000000001	0.07692304
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0009615380000000001	0.07692304
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.07692304
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	0.07692304
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0009615380000000001	0.07692304
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.07692304
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	0.07692304
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0009615380000000001	0.07692304
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.0009615380000000001	0.07692304
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0009615380000000001	0.07692304
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	0.07692304
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0009615380000000001	0.07692304
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.07692304
YUNIS-VARON SYNDROME	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.07692304
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.07692304
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0009615380000000001	0.07692304
WARSAW BREAKAGE SYNDROME; WABS	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0009615380000000001	0.07692304
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0009615380000000001	0.07692304
TEMTAMY SYNDROME; TEMTYS	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	0.07692304
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.07692304
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0009615380000000001	0.07692304
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0009615380000000001	0.07692304
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0009615380000000001	0.07692304
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.07692304
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.07692304
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0009615380000000001	0.07692304
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.07692304
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	0.07692304
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 14	0.0009615380000000001	0.07692304
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.0009615380000000001	0.07692304
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0009615380000000001	0.07692304
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.07692304
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0009615380000000001	0.07692304
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.0009615380000000001	0.07692304
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.07692304
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0009615380000000001	0.07692304
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0009615380000000001	0.07692304
GRISCELLI SYNDROME TYPE 1	0.0009615380000000001	0.07692304
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 15	0.0009615380000000001	0.07692304
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0009615380000000001	0.07692304
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0009615380000000001	0.07692304
CHROMOSOME 16Q22 DELETION SYNDROME	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.0009615380000000001	0.07692304
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	0.07692304
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0009615380000000001	0.07692304
COFFIN-SIRIS SYNDROME 3; CSS3	0.0009615380000000001	0.07692304
COFFIN-SIRIS SYNDROME 4; CSS4	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0009615380000000001	0.07692304
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0009615380000000001	0.07692304
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.07692304
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0009615380000000001	0.07692304
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0009615380000000001	0.07692304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0009615380000000001	0.07692304
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.07692304
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0009615380000000001	0.07692304
PRIMROSE SYNDROME; PRIMS	0.0009615380000000001	0.07692304
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	0.07692304
PEHO SYNDROME; PEHO	0.0009615380000000001	0.07692304
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.07692304
RIGID SPINE SYNDROME	0.0009615380000000001	0.07692304
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0009615380000000001	0.07692304
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.07692304
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0009615380000000001	0.07692304
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.07692304
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.0009615380000000001	0.07692304
RING CHROMOSOME 13 SYNDROME	0.0009615380000000001	0.07692304
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.07692304
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0009615380000000001	0.07692304
SULFOCYSTEINURIA	0.0009615380000000001	0.07692304
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0009615380000000001	0.07692304
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED 41	0.0009615380000000001	0.07692304
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0009615380000000001	0.07692304
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED 99	0.0009615380000000001	0.07692304
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.07692304
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.07692304
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.07692304
MARINESCO-SJOGREN SYNDROME; MSS	0.0009615380000000001	0.07692304
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.07692304
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.07692304
JACOBSEN SYNDROME	0.0009615380000000001	0.07692304
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.07692304
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.07692304
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.07692304
HOLOPROSENCEPHALY 1; HPE1	0.0009615380000000001	0.07692304
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.07692304
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	0.07692304
ACROCALLOSAL SYNDROME; ACLS	0.0009615380000000001	0.07692304
ADDUCTED THUMBS SYNDROME	0.0009615380000000001	0.07692304
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.07692304
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0009615380000000001	0.07692304
LATERAL MENINGOCELE SYNDROME	0.0009615380000000001	0.07692304
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.07692304
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0009615380000000001	0.07692304
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0009615380000000001	0.07692304
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	0.07692304
FONTAINE PROGEROID SYNDROME; FPS	0.0009615380000000001	0.07692304
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0009615380000000001	0.07692304
KAGAMI-OGATA SYNDROME	0.0009615380000000001	0.07692304
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	0.07692304
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0009615380000000001	0.07692304
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0009615380000000001	0.07692304
GOLDBERG-SHPRINTZEN SYNDROME	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 4	0.0009615380000000001	0.07692304
GLUTAMINE DEFICIENCY, CONGENITAL	0.0009615380000000001	0.07692304
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0009615380000000001	0.07692304
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0009615380000000001	0.07692304
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0009615380000000001	0.07692304
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.07692304
LEGIUS SYNDROME	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 7	0.0009615380000000001	0.07692304
LISSENCEPHALY 3; LIS3	0.0009615380000000001	0.07692304
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.07692304
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0009615380000000001	0.07692304
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0009615380000000001	0.07692304
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0009615380000000001	0.07692304
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	0.07692304
MEND SYNDROME; MEND	0.0009615380000000001	0.07692304
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0009615380000000001	0.07692304
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0009615380000000001	0.07692304
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.07692304
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.07692304
PETTIGREW SYNDROME	0.0009615380000000001	0.07692304
MENKES DISEASE	0.0009615380000000001	0.07692304
MENTAL RETARDATION, X-LINKED 1	0.0009615380000000001	0.07692304
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	0.07692304
MICROPHTHALMIA, SYNDROMIC 1	0.0009615380000000001	0.07692304
TARP SYNDROME; TARPS	0.0009615380000000001	0.07692304
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	0.07692304
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.0009615380000000001	0.07692304
TIMOTHY SYNDROME; TS	0.0009615380000000001	0.07692304
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0009615380000000001	0.07692304
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	0.07692304
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0009615380000000001	0.07692304
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0009615380000000001	0.07692304
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0009615380000000001	0.07692304
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0009615380000000001	0.07692304
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0009615380000000001	0.07692304
LISSENCEPHALY 5; LIS5	0.0009615380000000001	0.07692304
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.07692304
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0009615380000000001	0.07692304
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0009615380000000001	0.07692304
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0009615380000000001	0.07692304
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0009615380000000001	0.07692304
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0009615380000000001	0.07692304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0009615380000000001	0.07692304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0009615380000000001	0.07692304
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0009615380000000001	0.07692304
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0009615380000000001	0.07692304
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0009615380000000001	0.07692304
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 32; JBTS32	0.0009615380000000001	0.07692304
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0009615380000000001	0.07692304
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.07692304
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	0.07692304
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0009615380000000001	0.07692304
JABERI-ELAHI SYNDROME; JABELS	0.0009615380000000001	0.07692304
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0009615380000000001	0.07692304
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0009615380000000001	0.07692304
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.0009615380000000001	0.07692304
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0009615380000000001	0.07692304
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0009615380000000001	0.07692304
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0009615380000000001	0.07692304
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	0.07692304
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	0.07692304
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0009615380000000001	0.07692304
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	0.07692304
ROIFMAN SYNDROME	0.0009615380000000001	0.07692304
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.07692304
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.07692304
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.07692304
PERIPHERAL HYPOTHYROIDISM	0.0009615380000000001	0.07692304
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.07692304
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.07692304
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.07692304
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.07692304
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.07692304
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.0009615380000000001	0.07692304
STT3A-CDG	0.0009615380000000001	0.07692304
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	0.07692304
COG1-CDG	0.0009615380000000001	0.07692304
OROFACIODIGITAL SYNDROME TYPE 6	0.0009615380000000001	0.07692304
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	0.07692304
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	0.07692304
OGDEN SYNDROME	0.0009615380000000001	0.07692304
SYDENHAM CHOREA	0.0009615380000000001	0.07692304
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.07692304
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	0.07692304
TARP SYNDROME	0.0009615380000000001	0.07692304
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0009615380000000001	0.07692304
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	0.07692304
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.07692304
STT3B-CDG	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0009615380000000001	0.07692304
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	0.07692304
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.07692304
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0009615380000000001	0.07692304
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.07692304
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0009615380000000001	0.07692304
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0009615380000000001	0.07692304
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.07692304
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0009615380000000001	0.07692304
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.07692304
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0009615380000000001	0.07692304
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0009615380000000001	0.07692304
SSR4-CDG	0.0009615380000000001	0.07692304
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.0009615380000000001	0.07692304
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0009615380000000001	0.07692304
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.07692304
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	0.07692304
MEND SYNDROME	0.0009615380000000001	0.07692304
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.07692304
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0009615380000000001	0.07692304
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.0009615380000000001	0.07692304
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.07692304
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	0.07692304
CAP MYOPATHY	0.0009615380000000001	0.07692304
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	0.07692304
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0009615380000000001	0.07692304
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.07692304
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.07692304
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.0009615380000000001	0.07692304
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0009615380000000001	0.07692304
NEMALINE MYOPATHY 10	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0009615380000000001	0.07692304
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0009615380000000001	0.07692304
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.07692304
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.07692304
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.07692304
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	0.07692304
WHITE-SUTTON SYNDROME; WHSUS	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.07692304
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0009615380000000001	0.07692304
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0009615380000000001	0.07692304
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.0009615380000000001	0.07692304
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0009615380000000001	0.07692304
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0009615380000000001	0.07692304
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0009615380000000001	0.07692304
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.07692304
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0009615380000000001	0.07692304
INFANTILE LIVER FAILURE SYNDROME 1	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0009615380000000001	0.07692304
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0009615380000000001	0.07692304
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.07692304
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.07692304
HELSMOORTEL-VAN DER AA SYNDROME	0.0009615380000000001	0.07692304
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0009615380000000001	0.07692304
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 21	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0009615380000000001	0.07692304
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0009615380000000001	0.07692304
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0009615380000000001	0.07692304
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0009615380000000001	0.07692304
XIA-GIBBS SYNDROME	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0009615380000000001	0.07692304
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0009615380000000001	0.07692304
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0009615380000000001	0.07692304
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0009615380000000001	0.07692304
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0009615380000000001	0.07692304
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 27	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 28	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0009615380000000001	0.07692304
SIFRIM-HITZ-WEISS SYNDROME	0.0009615380000000001	0.07692304
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.07692304
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	0.07692304
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0009615380000000001	0.07692304
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0009615380000000001	0.07692304
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0009615380000000001	0.07692304
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0009615380000000001	0.07692304
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.07692304
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.0009615380000000001	0.07692304
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.07692304
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.07692304
PSEUDO-TORCH SYNDROME 2	0.0009615380000000001	0.07692304
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0009615380000000001	0.07692304
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0009615380000000001	0.07692304
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0009615380000000001	0.07692304
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.07692304
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0009615380000000001	0.07692304
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0009615380000000001	0.07692304
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.07692304
AU-KLINE SYNDROME; AUKS	0.0009615380000000001	0.07692304
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0009615380000000001	0.07692304
RING CHROMOSOME 14 SYNDROME	0.0009615380000000001	0.07692304
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.07692304
SMITH-KINGSMORE SYNDROME; SKS	0.0009615380000000001	0.07692304
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0009615380000000001	0.07692304
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0009615380000000001	0.07692304
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0009615380000000001	0.07692304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0009615380000000001	0.07692304
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0009615380000000001	0.07692304
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0009615380000000001	0.07692304
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 25	0.0009615380000000001	0.07692304
JOUBERT SYNDROME 26	0.0009615380000000001	0.07692304
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.07692304
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.0009615380000000001	0.07692304
XQ25 MICRODUPLICATION SYNDROME	0.0009615380000000001	0.07692304
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0009615380000000001	0.07692304
HEART AND BRAIN MALFORMATION SYNDROME	0.0009615380000000001	0.07692304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	0.07692304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0009615380000000001	0.07692304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.07692304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0009615380000000001	0.07692304
ZTTK SYNDROME; ZTTKS	0.0009615380000000001	0.07692304
